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Though more than a decade has passed since the completion of 
The Human Genome Project, the knowledge derived from it has had little 
impact on our understanding of human health. The reason for this 
knowledge gap is that only 6.5-10% of the human genome appears to 
have direct functionality, with the remainder of functional genome 
elements existing hidden within “junk DNA”. Much effort has been 
directed towards identifying such regulatory components, like the 
ENCyclopedia of DNA Elements (ENCODE) project, however, such studies 
are incapable of distinguishing specific from non-specific protein-DNA 
binding, or intrinsic vs. environmentally affected binding affinity.  
A new method of producing randomly methylated DNA libraries is 
presented here which should help bridge this knowledge gap. Using 
mobility shift assay (EMSA), cleavage-qPCR, and immunoprecipitation 
sequencing (IP-Seq), this method was used to probe the activity and 
binding strength between Type II restriction endonucleases and 
randomly methylated DNA.  The generation of randomly methylated 
libraries of genetic material will enable future studies of protein binding 
affinity, relative to both genetic sequence, and the presence of local and 
distant DNA methylation. Such experiments can integrate further 
elements of epigenetic complexity into current methods for identifying 
binding motifs of proteins, and provide further insight into the 
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Chapter 1 – History of Epigenetics: 
1.1 – The Human Genome Project 
       The Human Genome Project was a massive undertaking for genetic 
science. To date, it remains the largest collaborative biological effort in 
history, requiring almost two decades of work, and collaboration between 
twenty universities across the globe1. This effort, while unprecedented in 
scope, promised benefits that justified such an investment. The theory 
went that by identifying functional elements within the genome that 
guided protein expression, scientists would have developed a tool that 
could accurately predict an individual’s phenotypic response to 
practically any biological stimulus simply by examining their DNA. 
Such a tool would be invaluable to the fields of biological and 
medical research. By identifying oncogenes, for example, doctors could 
diagnose likely cancer onset in their patients far in advance of the 
development of dangerous symptoms. These doctors could then prescribe 
new personalized drugs, designed specifically to counteract their cancer, 
potentially halting the spread of the disease entirely. Through further 
research, these techniques could be applied to other diseases as well, 
paving the way for a myriad of effective new drugs with boosted potency, 
and greatly reduced risk of undesired side effects.  
Moreover, the benefits of Human Genome Project extend beyond 
human biology. Using the lessons learned in completing the massive 




organisms would be far less time consuming, and labor intensive. 
Generating similar genomic mappings for common crops and livestock 
for example, could pave the way for breakthroughs in agricultural 
output, the development of cheap biofuels, as well as synthetic biological 
development, and much more. In effect, unlocking the human genome 
would crack the mystery of the central dogma of molecular biology, 
letting scientists read the blueprints for all life, and theoretically, make 
any alteration they pleased. 
Upon its official completion in 20032, two years ahead of schedule, 
the scientific world held its breath in anticipation, confident that the 
inevitable string of new breakthroughs was soon to follow. However, such 
developments have been slow in coming, for while scientists did indeed 
have a complete genetic catalogue of the human genome, scientists have 
struggled to interpret this new data and identify functional elements 
within the genome. 
It took little time to establish that roughly 99% of nucleotides in 
the human genome didn’t appear to directly code for proteins2.Later 
studies determined that the majority of conserved regions (in mammals) 
consisted of non-coding regions3,4,5,6, and that most loci associated with 
phenotypic expression were found within non-coding regions as well7,8. 
These studies and others suggested the inescapable conclusion there 




stored not directly in the genetic code, but in tangential epigenetic 
alterations external to DNA. 
The relationship between these epigenetic mechanisms and gene 
expression has been intensively studied for the past thirty years. Since 
the discovery that DNA methylation had an impact on gene regulation35 
below35, research has expanded to encompass several other epigenetic 
modifications, as well as the focused study of complete epigenomes. In 
recent years, there have been substantial efforts to characterize changes 
within the human epigenome, including The Cancer Genome Atlas 
(TCGA) project, The Epigenetics Roadmap9, and The ENCyclopedia of 
DNA Elements (ENCODE)3. 
Common human disease’s and the methylation state of DNA have 
been linked through this type of work,10,11 though the general functional 
mechanism of methylation remains elusive. Despite present efforts, there 
remain several key obstacles to overcome in order to characterize the 
specific effects of methylation.  At present there is no clear correlation 
between the location and or degree of methylation change and gene 
expression, so determining areas where methylation has a direct causal 
effect remains elusive.  
Further confounding efforts is the lack of high-throughput 
methods that can determine both the specific location of protein binding, 
as well as the strength of each particular bond to DNA. The most modern 




ENCODE, like formaldehyde cross-linked immunoprecipitation, are 
designed primarily to establish where protein has bound onto genetic 
material, and can only determine the strength of particular bonds under 
certain limited circumstances. This deficiency makes it surprisingly 
difficult to characterize and differentiate relevant binding motifs, 
resulting in many studies relying heavily on complex biostatistical 
analysis in order to make sense of data.12  
On the other end of the spectrum, other classical methods of 
probing protein-DNA binding dynamics also fall short. Studies have 
shown that electrophoretic mobility shift assays (EMSA)13, DNA 
footprinting14, and surface plasmon resonance (SPR)15 also have difficulty 
determining the strength of protein binding to DNA. Even single-molecule 
analytical techniques like atomic force microscopy (AFM)16 which have 
been used to determine binding strength of protein-DNA complexes in 
the past, are ill suited to tackling this problem, as they do not scale well 
to high-throughput analysis and typically require expensive or 
complicated experimental setups to obtain results. 
 What all of this suggests is that currently existing tools are 
insufficient to tackle this problem. High-throughput methods are 
essential for modern biological research, but if they only generate simple 
characterizations of epigenetic effects without biophysical insight, they 
stand little chance of establishing the underlying mechanisms of 




methylation impacts protein binding to DNA, we can potentially develop 
experimental tools and methods which would substantially reduce 
workload by determining which methylation mutations are significant.  
Once such functional elements have been identified, studies can be 
undertaken to determine how specific instances of methylation effect 
gene expression at varying points in the genome, granting us insight into 
how such a result might be ameliorated, or even reversed.  
If present suspicions prove correct, and methylation outside of 
motifs or outside of cognate binding sites does indeed have a direct effect 
on their expression, a potentially missing link may be found in the 
fundamental dogma of molecular biology, and the promises of the human 
genome project may yet come to fruition. It is with these possibilities in 
mind that we intend to study methylation in the context around a 
putative binding site as well as within the binding site of well examined 
and understood protein-DNA interactions, as well as highlight the 
specific methods with which further studies could be completed. Through 
standardizing these methods, we hope to pave the way for a swifter 
development of further epigenetic study, as well as a deeper 







1.2 – Epigenetics vs. Genetics 
The precise meaning of the term ‘epigenetics’ was a troublesome 
question for the scientific community during the 20th century. By 
necessity, epigenetics evolved rapidly in response to our increasingly 
sophisticated understanding of genes and gene expression.  
The first of these was Conrad Waddington, a researcher 
knowledgeable in both genetic and developmental biology, who originally 
coined the term epigenetics in 193917. In early stages, epigenetics was 
broadly defined as the study of the genetic program for development, as 
it proceeded step by step. Applying this idea macroscopically, he 
developed the term epigenotype, which he defined in even broader terms 
as “The total developmental system consisting of interrelated 
developmental pathways through which the adult form of the organism is 
realized.”18 Despite the considerable breadth, and absence of depth of 
such definitions, epigenetics remained a topic of intermittent discussion 
amongst biologists19,20, seeing as not all heritable traits could easily be 
explained purely through genetics.  
In 1996, Russo et al. defined epigenetics as “[T]he study of 
mitotically and or mitotically heritable changes in gene function that 
cannot be explained by changes in DNA sequence.”21 What is notable 
about this definition, as well as the field of epigenetics itself, is how it is 
cast explicitly as the necessary obverse of genetics. The field studies a 




various chemical modifications external to DNA can alter how 
information in cells is stored, transmitted, and ultimately expressed as 
phenotype, and bridge the gap between genetics and developmental 
biology. 
This was not always the case however. Following the discovery of 
the molecular structure of DNA by Watson and Crick in 1953 
establishing it as the primary vector for genetic information, epigenetics 
was recast as a foil of traditional genetic research, focusing on heritable 
changes that did not result directly from coded DNA. Little progress was 
made in identifying such changes however, and as a result epigenetics 
played second fiddle to genetics research for the remainder of the 20th 
century. 
With the publication of more sophisticated genetic models however, 
particularly those concerning DNA methylation and its impact on gene 
expression, epigenetics began to pick up speed, with an enormous 
amount of progress being made in the past 30 years18. It became 
increasingly apparent that the complexity of gene expression cannot be 
understood through the lens of genetic study alone. In order to fulfill the 
promises of the human genome project, a more directed examination of 
epigenetics, and the epigenome has been undertaken.3 How this came to 
be however, can be better understood with an examination of how 





1.3 – Unanswered Questions 
Though the relationship between genetic code and developmental gene 
activity was clarified immensely during the mid-20th century, it became 
increasingly difficult to ignore several mechanisms that defied traditional 
genetic explanation. A basic but biologically fundamental example would 
be that of differentiated cells like lymphocytes and fibroblasts 
maintaining phenotype through cycle after cycle of cell division. It was 
understood that all cells from the same organism contained the same 
genome, and while methods of gene regulation were understood as early 
as 196118, these were not sufficient to explain how the expression pattern 
of these cells could be stably maintained over several generations. Within 
each cell type, the specialized genes determining its phenotype were 
somehow permanently turned on (with the remainder of specialized 
genes permanently turned off), and passed on heritably to further 
generations without apparent genetic cause.  
Stem cells posed similar problems. While such cells are originally 
unspecialized, when they divide, a new differentiated cell is produced 
along with another undifferentiated cell. In other words, stem cell 
division results in an alteration of gene activity of the subsequent 
specialized cell, despite all having the same genetic input. Additionally, 
they are capable of long-term self-renewal22, meaning stem cells can self-
replicate and remain unspecialized for years in vivo, depending on the 




growing such cells in vitro without having them differentiate, with a gap 
of nearly twenty years between the isolation of mouse and human 
embryonic stem cells23,24, such a mechanism is all the more remarkable. 
Yet another example would be the X chromosome in female 
placental mammals. In 1959, Ohno et al. demonstrated that X 
chromosomes in female mammals appeared to be different, with one 
highly condensed and heterochromatic chromosome, and another quite 
similar to the other autosomes in the cell.25 Females possess two X 
chromosomes in each of their cells. During development, one of these two 
chromosomes is permanently and randomly inactivated, leaving the 
remaining X chromosome active in the cell. Gene expression is altered 
permanently, and passed on hereditarily, once again external to the 
currently existing genetic model. Reductively, these examples must 
therefore be attributable to underlying epigenetic mechanisms; though 











1.4 – The Importance of Methylation 
Scientists were aware of DNA methylation as early as the 
identification of DNA as a genetic vector26,27, though its significance at 
the time was poorly understood. Many scientists had proposed that 
methylation might have a role in gene regulation28, but it would take over 
thirty years for any evidence to emerge supporting this claim.  
DNA methylation is one of the key means of epigenetic modification 
and expressive regulation found in biology. Methylation acts upon DNA 
in a variety of different ways, with alternate mechanisms having been 
recorded in plants, fungi, bacteria, and vertebrates, the characteristics 
and biological uses of which vary drastically.62 
DNA methylation is a covalent modification of DNA, which only 
occurs on a cytosine base in mammals. Additionally, when such 
cytosines are methylated, the single methyl group (-CH3) is positioned 
carbon 5, generating 5mCytosine. Most often, DNA methylation occurs at 
CpG dinucleotides, which themselves can be fully methylated if both 
strands are modified, or hemi-methylated if only one strand has a methyl 
modification. These configurations can be better described as 
symmetrically or asymmetrically modified, as it illustrates more clearly 
the importance of the palindromic properties of CpG dinucleotides.   
The majority of CpG dinucleotides found in the human genome are 
methylated under normal circumstances, and those left unmethylated 




The methylation state of regions of CpG dinucleotides has been found to 
be greatly significant, with much study devoted to the relative 
distribution of CpG islands in the genome, and their tendency to be 
found within the promoter region of genes29,30. Observations noting that 
unmethylated CpG islands are associated with promoters of important 
genes expressed in most cells, called ‘housekeeping genes’, led to the 
hypothesis that methylation played an important role in regulating gene 
expression.31 
1.4.1 – Evolution and Function of Methylation 
Far from a novel mechanism, Methylation is an ancient 
phenomenon, having first evolved in prokaryotic organisms as a means 
of defending against foreign DNA coming from viruses, etc. by relying on 
specific DNA methyltransferase enzymes, and complementary restriction 
enzymes.32,31 The methyltransferases would scan the host organism’s 
DNA, and selectively methylate the DNA at short, palindromic sequences. 
Restriction enzymes would cleave this same sequence of DNA, only if it 
was found to be unmethylated. These two groups of enzymes working 
together allowed for bacteria and other prokaryotes to be able to 
distinguish host from intruder DNA, and quickly destroy it before it could 
hijack the organism’s cellular machinery. 
Methylation works exceedingly well in this capacity for prokaryotic 
cells, but would present some issues if it were to perform in the same 




methylation have been repurposed to allow dividing cells to inherit states 
of gene activity, as well as act in several epigenetic regulatory processes 
active in all eukaryotic organisms.62 
As stated, cytosine methylation is associated with several 
epigenetic phenomena: The first of these, which is widely conserved and 
likely represents the original ancestral role of DNA methylation, is 
“genome maintenance,” where methylation of repetitive elements of the 
genome enables the control of genes and mobile elements (primarily 
transposons)33. 
As it happens, mammalian and plant genomes contain more 
transposons than genes overall, and the majority of DNA methylation in 
their genetic sequences tends to be found concentrated at these 
transposons. The relatively high density of methylation serves a very 
important purpose; as it suppresses the transcription or transposition of 
transposon sequences, preventing their propagation through the genome. 
This mechanism is similar to that found in prokaryotic organisms, in 
that it offers a means of protecting against genomic parasites.30  
Two papers were published in 1975, proposing a molecular model 
that could explain the features of complex organisms mentioned above, 
based on the enzymatic methylation of cytosine nucleotides in DNA. 
These proposals had a great deal in common with one another 
(remarkable, considering how they were working independently at the 




methylation of cytosines in mammalian DNA could have a significant 
effect on gene expression, and that changes in methylation state could be 
the key to explaining how genes are activated or inactivated during 
development.  
Both observed the propensity for methylation to occur at CpG 
doublets, which can be thought of as short, genetically palindromic 
sequences. This is because the reverse transcription of CG is CG, when 
5’-3’ directionality is observed.  
To make such 
methylation states 
heritable however, a 
further mechanism 
must be involved. 
During DNA 
replication, a fully 
methylated strand of DNA is unzipped, resulting in the separation of the 
5’ and 3’ strands. These methylated, single stranded DNA molecules can 
then act as templates for the creation of duplicate DNA molecules. 
Polymerases would add new unmethylated dNTP’s to these daughter 
molecules, resulting in strands that are hemi-methylated (or 
asymmetrically methylated). If an enzyme existed, they argued, which 
could completely methylate strands of hemi-methylated DNA, then 




methylation states could be stably inherited, and potentially serve as a 
vector for gene expression. 
1.4.2 – Methylation and Restriction Enzymes 
Their arguments were elegant, but entirely theoretical, as neither 
had proof for the effect of methylation on gene activity. But following that 
year, an increasing body of evidence began to emerge concerning cancer 
cell gene expression and mutation, and both Riggs and Holliday argued 
that methylation might play a part in the malignant tendencies of 
cancerous cells.36,37 The development of new molecular biological 
techniques such as molecular cloning38 and DNA sequencing39, gave 
researchers the tools necessary to screen for methylation state in specific 
DNA sequences. Neither of these techniques would be possible, however, 
without restriction enzymes40. 
Restriction enzymes, or restriction endonucleases, are specialized 
enzymes capable of cleaving DNA at highly specific recognition sites. 
They do this by making an incision into both strands of the sugar 
phosphate backbone of the DNA double helix, and their reliability and 
precision makes them 
invaluable tools for gene 
cloning, and protein 
expression experiments.  
Of particular importance to 
epigeneticists were subsets of 




restriction enzymes that shared the same target sites, but responded 
differently depending on the DNA’s methylation status. HpaII and MspI 
are examples of such endonucleases, known as isoschizomers. Both 
enzymes would target and cut at the sequence 5’-CCGG-3’, cleaving 
between the two cytosines on either end of the DNA strand; however 
when the second C is methylated, HpaII can no longer cleave the DNA.  
Using such isoschizomers, researchers were able to determine the 
methylation status of promoter regions of the genome, noting in the 
majority of cases that highly methylated genes were inactive, while 
unmethylated genes remained active.41   
1.4.3 – Methylation, and Disease Studies 
Such discoveries lead to an explosion of activity, as the presence of 
a more subtle form of inheritance not connected to sequence changes in 
DNA. Of particular importance was the work of Feinberg and Vogelstein, 
who in 1983 published a study connecting hypomethylation of genes in 
cancer cells to the presence and metastasis of cancer in humans.42 
Further studies noted that hypermethylation of identified tumor 
suppressor genes had similar oncogenic effects.43 These domains can 
increase cellular plasticity and shifts in gene expression with disastrous 
effects for the cell.  
These and other discoveries in the 1980’s could not be adequately 
explained by currently existing genetic models, but researchers were slow 




Holliday is credited for resurrecting / re-popularizing the term 
epigenetics in the 1990’s with his paper “The inheritance of epigenetic 
defects” published in 198744,45. Soon afterwards, John Maynard Smith 
coined the term “Dual Inheritance”, establishing the existence of classical 
genetic inheritance, based on changes to DNA sequence, and epigenetic 
inheritance, classified as anything not based on changes to DNA 
sequence. As the 21st century dawned, genetics, gene function, and 
epigenetics exposure have increasingly become integrated in the process 
of studying cancer, as well as other diseases like diabetes, autoimmune 
disease, and even aging.46   
1.4.4 – Beyond Methylation 
Additional epigenetic mechanisms beyond DNA methylation have 
also been explored. For example, chromatin structure and its interface 
with gene expression has emerged as an active field of epigenetic 
research48. Chromatin is the complex of DNA, RNA and protein found in 
cells, and depending on its conformational structure, can be accessible, 





Evidence has emerged 
suggesting that histone 
modification, via 
acylation and 
methylation, play a 
crucial role in switching 
between open and 
closed chromatin 
states47.   
 
The mechanism by which chromatin configuration can be inherited 
is still debated; however the evidence that DNA methylation is the source 
of shifting chromatin states is compelling18,47,48. Further research 
regarding the potential role of RNA in epigenetic events has also been 
proceeding rapidly in recent years. 
1.5 – The Human Epigenome Project 
As stated before, the Human Genome Project was an 
unprecedented milestone of molecular biology, yet it ultimately provided 
more questions than answers for biologists. With this lesson in mind, the 
epigenome project has been launched, aiming to identify the pattern of 
DNA methylation in numerous cell types. While utilizing numerous 
analytical techniques to this end, the project ultimately hinges on the 
usage of bisulfite sequencing, in order to check for methylation at every 
Figure 3:  “Chromatin Modifications and Their Function.” Cell 128, no. 4  




relevant site in DNA. While it has been vastly improved since first 
developed in 1992 by Frommer et al.49, the chemistry underlying the 
mechanism remains unchanged.  
Bisulfite ions actively deaminate cytosine nucleotides, converting  
them to uracil, a RNA nucleobase. However, the additional methyl group 
in 5-methylcytosine protects it from nucleophilic attack, leaving them 
unaffected by the bisulfite ions. When this bisulfite-treated DNA is 
amplified, DNA polymerases will recognize 
the 5-methylcytosine as cytosine, and the 
uracil nucleobases as thymines, and create 
new strands accordingly.  
The amplified DNA can then be sequenced, 
and compared with the original, non-
methylation sensitive sequence data to 
determine which cytosines were methylated 
(remaining C’s in the bisulfite data) or unmethylated (recorded as T’s in 
the bisulfite data).  While data is being produced continuously 
concerning the methylation status of various cell types, the underlying 
mechanisms behind the effects of DNA methylation on gene regulation 
still remain poorly understood. In order to derive the most benefit from 
the ongoing epigenome project, much work remains towards this end. 





Chapter 2 – Characterizing Epigenetic Effects: 
2.1 – Methylation and DNA 
 Despite having considerable impact on gene expression, the effects 
of methylation on DNA structure is surprisingly subtle. Some aspects of 
why this is so are counterintuitive, but can be better understood by 
examining the tertiary structure of a DNA strand.  
 
Figure 5: Unmethylated and Methylated Strands of DNA. 
These PyMOL images represent the same strand of DNA (sequence 
5’-ACCGCCGGCGCC-3’)50, chosen due to its having an internal CpG 
doublet, which is completely methylated in the second image. The DNA 
itself has been color coded according to nucleotide (A-> azure, C-> 
crimson, G-> green, T-> yellow), with methyl groups shown as space-
filled models in magenta.  
Comparing the methylated and unmethylated sequences, several 




does not appear to modify base pairing, as both C and 5mC (methylated 
cytosine) pair with G in DNA sequences without interference from DNA 
mismatch repair51. Additionally, methylation has a very minor effect on 
the shape of the DNA double helix, with the additional methyl groups 
residing comfortably in the major grove of DNA, resulting in only minor 
conformational change.  
Considering the demonstrated effects that epigenetic modification can 
have on gene expression, this result is somewhat underwhelming; and in 
general, the molecular mechanisms explaining the function of DNA 
methylation are poorly understood52. However, several discoveries have 
recently emerged that can potentially explain the functional impact of 
cytosine methylation, though further experimental verification remains 
necessary. Kinetic experiments and Monte Carlo simulations have shown 
that while methylation does not affect DNA bend magnitude and 
direction, it can result in a loss of DNA flexibility, as well as subtle 
under-winding of methylated CpG dinucleotides53,54.  
 2.1.1 – Methylation Distribution 
The distribution of CpG dinucleotides in the mammalian DNA is 
also a source of interest for researchers. The human genome is roughly 
three billion base pairs in length. Assuming an equal frequency of DNA 
bases (P(A) = P(C) = P(G) = P(T) = ¼), we should expect that CpG 
dinucleotides should comprise roughly 1/16th of the genome, or 




represented, with only about forty million in the human genome. Of this 
smaller number, 80% are methylated at any given time,55 making the 
total number of methylated CpGs around forty million.  
In healthy human cells, these CpGs are distributed unevenly 
throughout the genome, concentrated primarily in areas known as CpG 
islands. These islands, as previously mentioned, commonly correspond 
to the location of promoter regions in DNA. Methylation of these sites is 
also uneven, found primarily within gene bodies, inter-genic regions, and 
in repeated sequences, while those found at CpG islands are typically 
unmethylated. This is not universally true, as many some promoter 
regions like OCT4 have been found to be methylated in somatic 
cells56,57,58; but for the most part CpG islands are free of methylation. 
 
Figure 6: Methylation Pattern of a healthy cell. 
CpG doublets are shown as blue lines, while additional methyl groups are shown as red dots. 
Defossez, P. (2011), "Proteins that Bind Methylated DNA", DNA Methylation: Physiology, pathology 
and disease, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London 
 
The methylation patterns in cancer cells are markedly different 
from healthy cells. The total amount of methylation goes down sharply, 
primarily in the repeat sequences of the genome.59,60 Conversely, some 





Figure 7: Methylation Pattern of a Cancerous Cell. 
In cancer cells; CpG islands become hypermethylated, while total amount of methylation decreases. 
Defossez, P. (2011), "Proteins that Bind Methylated DNA", DNA Methylation: Physiology, pathology 
and disease, The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London 
 
 The genetic basis of cancer is driven by the deactivation of 
oncogenes, and loss of tumor suppressor genes like p53, etc.61. These 
defensive genes come in pairs, with two copies of each per cell. If both 
genes are lost for purely genetic reasons, due to point mutations, or loss 
of heterozygosity, transformation can occur and cancer may develop.62 
However, these genes can also become lost for epigenetic reasons, as is 
the case when promoters become methylated, for example. DNA 
methylation therefore is tightly linked to cancer.61,55 
2.1.2 – Protein Interactions 
Proteins, such as many transcription factors, that bind to specific 
DNA sequences are essential for the proper regulation of gene 
expression.63 Identifying the specific sequences that each factor binds 
can help to elucidate regulatory networks within cells and how genetic 
variation can cause disruption of normal gene expression, which is often 
associated with disease. Traditional methods for determining the 
specificity of DNA-binding proteins are slow and laborious, but several 
new high-throughput methods can provide comprehensive binding 




transcription factor binding locations, this information provides more 
detailed views of the regulatory circuitry of cells and the effects of 
variation on gene expression. 
Numerous studies have shown the regulatory effect DNA 
methylation can have on gene expression.68,68 Despite this recognition 
however, the mechanisms that drive these effects are themselves poorly 
understood. The reason for this is due in part to the contextual nature of 
these effects, and the difficulty scientists face in establishing what effects 
are in play.  
The presence of a methyl group itself represents a relatively small 
chemical alteration to DNA, but when added to cytosine, the biophysical 
properties of the nucleotide are changed sufficiently to affect its base 
readout.64 The presence of additional hydrophobic contacts alters 
cytosines presence in the major groove of DNA, while simultaneously 
altering its electrostatic profile and physical shape with regards to the 
minor groove. 
Recent evidence suggests that CpG methylation can increase 
DNase I activity and cleavage potential at bordering positions by orders of 
magnitude, simply through the resultant physical alterations to DNA 3D 
structure.65 This discovery, when considered in the context of the 
regulatory properties of CpG methylation, suggests a potential 
explanation of methylation sensitivity for transcription factors, and 




be considered in a vacuum. The biophysical qualities that result in the 
behavior of CpG methylated DNA also result in alterations to 
nucleosomic stability, which has enormous downstream effect on a long 
list of relevant epigenetic factors, such as local and global chromatin 
structure.66  
The disappointing conclusion to draw is that when the 
mechanisms underlying DNA methylation's regulatory properties on 
genetic expression are revealed, there will be few absolute rules that will 
guide the process. Due to the complexity of the underlying forces which 
drive the process, the epigenetic context of CpG methylation, rather than 
the content itself, will be what determines its behavior. 
2.2 – Methyl Binding Proteins 
While the link between DNA methylation and gene regulation is 
well categorized, and extensively studied, the underlying mechanism 
behind its operation is poorly understood. Numerous studies have 
established that DNA methylation can result in transcriptional silencing 
in mammalian cells. This is made possible by two separate methylation 
sensitive effects working in tandem. Firstly, DNA methylation can prevent 
certain transcription factors from binding to their specific target sites. An 
example of this can be seen with chromatin insulator protein CTCF, 
which is blocked from binding by DNA methylation67,68. At the same 
time, DNA methylation creates new binding sites for proteins which 




(MBPs). These proteins are an essential aspect for creating and 
maintaining a transcriptionally silenced chromatin environment69. 
Methylation binding proteins were actually discovered by accident 
by Adrian Bird et al. in 198970. Ironically, their initial intention was to 
identify factors which bind to unmethylated DNA, thereby protecting 
adjacent CpG islands from methylation,71. Instead, they discovered the 
first protein factors, MeCP1 and MeCP2, which bind specifically to 
methylated DNA sequences, and by isolating the Methyl-CpG-binding 
domain (MBD)72, other similar proteins containing the motif were 
identified via extensive homology search73,74. Considering the relative 
lack of protein databases at the time, the identification of these MBDs 
was all the more impressive. 
 Homology can only take you so far however, as similar molecular 
structure does not necessarily imply similar molecular function. In order 
to determine whether not a given protein binds to methylated DNA, 
further tests must be carried out. One of these tests, utilized in the 
characterization of each MBD is the Electrophoretic Mobility Shift Assay 
(EMSA) or Gel Retardation Assay.  
 The gel electrophoresis mobility shift assay is a common affinity 
electrophoresis technique used to detect and study protein complexes 
made with nucleic acids, and will be discussed in more technical detail in 
the experimental section. The scientific principles behind the method are 




and has changed little since it was first developed by Fried and 
Crothers.75,13  
Compared with similar assays, EMSA is procedurally simple, 
inexpensive, and capable of supporting a wide variety of different 
experimental conditions that alter binding conditions. Additionally, when 
using nucleic acids labeled using either radioisotopes, or biotinylation, 
the assay is surprisingly sensitive, capable of handling small 
concentrations and volumes of protein and nucleic acid.13  
As noted in previous sections, the rate at which an organic 
molecule propagates through a gel matrix is dependent on how fast it can 
migrate through pores in the gel. This navigation speed depends largely 
on the size and charge of the molecule, though shape and flexibility also 
come into play. All else being equal, according to the principles of 
electrophoretic separation a protein-DNA complex will migrate at a 
slower rate than DNA left unbound76,77. So, by incubating purified 
protein with two different ligands (either methylated or unmethylated 
forms of otherwise identical DNA), and then running mixture through the 
gel, the protein-DNA interaction can be detected as slowly migrating 
complexes.  
That said, the ability to resolve protein:DNA complexes depends 
largely on how stable the complex remains during each step of a given 
procedure. One of the benefits of subjecting protein:DNA complexes to a 




slow the rate of dissociation, and enables prompt reassociation of protein 
with sufficiently high local concentration78,79. However, dissociation of 
proteins can still be relevant experimentally, a topic which will be 
touched on later. 
While EMSA can be used to verify that a protein binds methylated 
DNA in vitro, this doesn’t necessarily imply that it will behave the same 
way in vivo. In order to establish whether a particular protein is a 
member of the MBP family, it must first be determined whether it would 
bind heavily methylated regions of DNA in living organisms.  
Technically there are further questions concerning whether or not 
proteins bind to heterochromatin, independent of DNA methylation, but 
such issues can be resolved by running similar experiments in cells with 
low levels of methylation. Additionally, if a target sequence for your 
protein has been identified, demethylating this sequence and examining 
whether or not proteins remain bound can provide further evidence for 
MBP characterization. 
2.3 – Methyl Binding Domains 
These approaches and others have been utilized by numerous labs 
over the past few decades, with an enormous contribution coming from 
Adrian Bird.80,81 Despite this work however, researchers have only 
discovered 9 human proteins that bind specifically and exclusively to 
methylated DNA. These proteins can be subdivided into separate 




subsequent proteins determined homologically. In chronological order of 
discovery, these families are: the MBD family, containing MeCP2, MBD1, 
MBD2 and MBD4, the zinc finger family, containing Kaiso, ZBTB4 and 
ZBTB38, and the SRA family, containing UHRF1, and UHRF1.  
 
Figure 8: The Three Families of MBD Binding Proteins in Mammals, with Key Domains. 
Fournier, Alexandra, Nobuhiro Sasai, Mitsuyoshi Nakao, and Pierre-Antoine Defossez. “The Role of 
Methyl-Binding Proteins in Chromatin Organization and Epigenome Maintenance.” Briefings in 
Functional Genomics 11, no. 3 (May 2012): 251–64. doi:10.1093/bfgp/elr040. 
Each family differs significantly in structure, meaning they possess 
completely different mechanisms for methylated DNA recognition. This 
implies naturally, that there are several ways to bind methylated DNA, 
and suggests the possibility that other DNA binding proteins may have 
similar properties, and remain undiscovered. Determining how these 
mechanisms work in vivo is far more difficult, however. For example, 
while the solution of the MBD domain bound to methylated DNA has 




proteins are capable of binding to specific sections of DNA, rather than 
all methylated DNA, irrespective of the sequence.  
The roles of methyl-binding proteins can be examined for further insight 
into epigenetic regulation. In numerous studies examining each MBP, it 
has been observed that they initiate heterochromatinization; i.e. they 
convert the formerly permissive euchromatin to a more repressed, closed 
off heterochromatin.83 This alteration appears to be the cause of 
repressed transmission seen in hypermethylated areas of DNA, rather 
than being directly caused by DNA methylation itself. Instead, DNA 
methylation attracts the binding of MBPs, which themselves catalyze the 
formation of heterochromatin. 
2.3.1 – MeCP2 
MeCP2, the first MBP discovered, has been strongly associated 
with the development of Rett Syndrome in humans.84,85 Rett Syndrome is 
a severe neurodevelopmental disorder that primarily effects young girls. 
After mentally progressing normally for their first 18 months, patients 
with Rett Syndrome rapidly regress, and exhibit severe mental deficiency.  
The vast majority of Rett patients are found to have mutations in 
MeCP2,86 and experiments on mice have resulted in symptoms that 
mirror Rett Syndrome, so it is safe to say that the absence of functional 
MeCP2 results in this sort of neurodevelopmental disorder. However, it 




MeCP2 targets might be involved, or what role methylation has to play in 
the development of the disorder.  
2.3.2 – MBD4 
MBD4, also from the MBD family, also has a strong affect on 
phenotype. When deleted in mice, they appear to be fairly healthy 
initially; however, they exhibit a greatly increased rate of mutation.87 
When examined in cancer models, the absence of MBD4 increased the 
development and frequency of tumor metastasis in affected mice. Further 
study has revealed that MBD4 works actively to repair damage from 
spontaneous deamination of methylated DNA.  
As it turns out, MBD4 is present in methylated regions to combat 
this issue under normal circumstances. A region of MBD4 has specific 
thymine glycosylase activity, which can remove offending T’s before they 
are altered by other repair machinery most of the time. While not perfect, 
MBD4 clearly has a role in limiting the number of point mutations 
generated in methylated regions of DNA. 
 
Figure 9: UDG and MBD4 performing separate DNA mismatch repairs.  
Defossez, P. (2011), "Proteins that Bind Methylated DNA", DNA Methylation: Physiology, pathology 




2.3.3 – Kaiso 
Kaiso is a zinc finger protein, named for the three zinc fingers it 
utilizes to target methylated DNA, as well as certain unmethylated 
consensus sequences.88 Further experimentation will be required to 
determine whether zinc finger proteins are more strongly drawn to 
methylated DNA, or sequence specific DNA, as presently researchers are 
unsure. Much like MBD4, when silenced in mice, there appears to be 
little sign of phenotype, but when applied to cancer-susceptible mice, 
such as those of the ApcMin model, the number and size of tumors 
developed actually decreases.89  
The reason for this change is currently unknown, but a potential 
theory involves interaction with methylated cancer suppressor genes.  
Cancer suppressor genes, which are normally unmethylated and 
expressive, are found to be abnormally methylated in early stages of 
cancer metastasis. Such methylation could potentially recruit MBPs like 
Kaiso, which would bind to the genes, and result in its suppression (and 
by extension, cancer expression). Operating in an overly methylated 
environment, Kaiso could potentially operate in a manner detrimental to 
the host organism, however further substantiation of this theory will be 







2.3.4 – UHRF1 
UHRF1, a member of the SRA family, is far more complex than 
MBD MBPs as can be seen in the image below. Studies in mice have 
shown that the deactivation of UHRF1 results in death in early 
embryonic stages of development (and is the only methyl-binding protein 
with a lethal phenotype).90 Examination of the deceased embryonic cells 
showed them to have significantly lower levels of DNA methylation.   
 
Figure 10: Schematic Representation of UHRF1  
Alhosin, Mahmoud, Tanveer Sharif, Marc Mousli, Nelly Etienne-Selloum, Guy Fuhrmann, Valérie B 
Schini-Kerth, and Christian Bronner. “Down-Regulation of UHRF1, Associated with Re-Expression of 
Tumor Suppressor Genes, Is a Common Feature of Natural Compounds Exhibiting Anti-Cancer 
Properties.” Journal of Experimental & Clinical Cancer Research 30, no. 1 (2011): 41. 
doi:10.1186/1756-9966-30-41. 
As mentioned previously, symmetrically methylated DNA 




these strands are left to their own devices, and continue to replicate over 
time as hemi-methylated strands, then the methylation site itself will 
eventually be lost through dilution as more and more replication cycles 
take place. UHRF1 has a specific affinity for hemi-methylated DNA 
molecules, and appears to be instrumental for the maintenance of 
methylation status after DNA replication.  
However, as seen in the examples above, UHRF1 is an exception in 
this regard. The majority of MBPs currently known appear to be non-
essential to their host organism; that is, their absence in living 
organisms does not result in a lethal phenotype. This is altogether 
surprising, considering that DNA methylation itself is absolutely vital for 
eukaryotes. Numerous studies have shown that tampering with DNA 
methylation enzymes results in lethality in the early embryonic stage of 
development; so how can this discrepancy be explained? 
2.4 – Restriction Modification Systems 
       As mentioned previously, proteins that cleave at or near specific 
restriction sites on double stranded DNA. These enzymes, also known as 
restriction endonucleases, fall into several types and subtypes depending 
on their specific structure, mechanism, and whether or not they cleave at 
or near their unique restriction sites. In general, after coming into 
contact with such a restriction site, restriction enzymes bind, and then 
sever both strands of the sugar-phosphate backbone of the DNA double 




mechanism utilized by bacteria and archaea to defend their DNA from 
contamination by foreign invasive DNA, destroying it and its ability to 
alter the host cell. 
       However, such enzymes cannot operate in a vacuum. Considering 
the short length of each restriction site, they will inevitably be found 
within prokaryotic genomes, and if left accessible, these defensive 
restriction enzymes to would eviscerate host DNA, doing tremendous 
harm to the host organism. As such, these enzymes have evolved to work 
in conjunction with a second class of modification enzymes, 
methyltransferases, which modify prokaryotic host DNA by adding 
methyl groups to specific base pairs on each strand. The additional 
methylation alters the restriction enzyme’s recognition site, making it 
impossible to cleave the strands of modified host DNA, thus protecting it 
from harm.   
These processes working together constitute what is known as a 
restriction modification system, and are essential for the protection of 
prokaryotic organisms against foreign genetic material. There are several 
different varieties of restriction modification systems: type I, type II, type 
IIS, type III, and type IV, named in order of discovery, and categorized 
according to characteristics of the enzymes involved. Despite their 
differences however, each system operates on the same principle of 




making such systems, particularly type II restriction endonucleases, of 
special interest to biologists.  
Type II restriction modification systems are both the simplest, and 
most common genomic defense mechanisms found in prokaryotic 
organisms.91 While other modification systems utilize a single molecular 
complex of bound endonuclease and methyltransferase, Type II 
modification systems rely on independently operating endonclease and 
methyltransferase proteins operating in tandem.  
The methyltransferase enzyme scans DNA, reading one strand at a 
time, and adding a methyl group to nucleotides once it has recognized its 
specific target sequence. These sequences are usually no more than 6 
base pairs in length, and are often palindromic. The now methylated 
strand is then examined by a corresponding endonuclease, which scans 
both strands of DNA, and responds to the same target site. In the event it 
comes across this sequence in a methylated state, it will not interact with 
it in any way. However, when the same sequence is found unmethylated, 
the endonuclease will promptly cleave the internal phosphodiester bonds 
holding the strand together, severing the DNA into two broken pieces 
either at, or very near the target location. 
The potential for self-harm on the part of the organism employing 
this form of modification system still exists, at least theoretically, but is 
balanced out by thermodynamics. Methyltransferases act as monomers, 




acting on singular strands more or less as soon as they come into 
contact. Type II endonucleases, however, operate as homodimers. 
2.5 – Use in Experimental Design 
Because the enzymes only act at specific locations, and can 
differentiate between alternate sequences and alternate methylation 
states, type two restriction endonucleases provided scientists with an 
extremely useful tool to utilize in genetic analysis. Sequences could be 
examined for point mutations, or single nucleotide polymorphisms (SNPs) 
with near perfect accuracy, which result in either uniform fragments, or 
an unbroken larger band when subjected to digestion, and visualized via 
gel electrophoresis. This treatment could be used to quickly establish the 
nature of a DNA segment without having to use more complex or 
expensive forms of gene sequencing. 
Restriction enzymes, in particular HpaII and MspI, possess several 
unique qualities that made them ideal candidates for study. 
Endonucleases bind very stably and specifically to DNA, and remain 
bound and unable to cleave at their specific binding sites when 
incubated in the absence of Mg2+. Additionally, HpaII and MspI are 
isoschizomers, meaning they both target and cleave the same recognition 
sequence on a strand of DNA (CCGG). However, this is not always the 
case. When this shared recognition site presents with an internally 





Chapter 3 - Experimental Outline: 
3.1 – DNA Sequence Isolation and Purification 
 As a preliminary to any experiments, suitable genetic material had 
to be created, purified, and tested to ensure an appropriate level of 
fidelity. To this end, several biotinylated primer pairs were designed, 
targeting short segments of the promoter of GSTP1 protein in human 
male DNA. Several sets of primers were designed to target various 
subsections of the promoter region flanking the GSTP1 gene. GSTP1 has 
been the subject of extensive study, and specific patterns of methylation 
in the region have been shown to be strongly correlated with the 
presence of prostate cancer92,93. These qualities made the GSTP1 
promoter region an excellent choice for the purpose of testing this new 
methodology, though theoretically any similar CpG-rich region would do. 
Planned future experiments will examine the binding regions of CTCF, 
and MeCP2 for similar reasons. 
Under normal circumstances, these primers are unable to interact 
with DNA, as it is bound in a double stranded configuration. To denature 
the DNA strands, a thermocycler is used, which raises the temperature of 
the samples above the Tm or “melting point” of DNA, at which half of DNA 
molecules are in a random coil configuration, meaning they are single 
stranded. The Tm for a particular genetic sequence varies dependent on 




Several suitable primer pairs were generated in Geneious94 
targeting small subsections of the GSTP1 promoter region. Each was 
designed to generate an amplicon between 100 and 300 bp (base pairs) 
in length, and to contain at least one binding site for either HpaII/MspI, 
or BamHI, a methylation insensitive endonuclease used as a control. The 
primer sets ultimately chosen for experimental verification of this method 
were thusly named H/M_1 and B_1, and will be the focus of the 
experimental analysis. Later iterations of these experiments utilized a 
nested PCR protocol, involving gel images of alternate primer sets can be 
found in appendix B. 
These primers were used in a series of PCR runs, generating 
amplicons from human male DNA template via separate reactions 
detailed below. To increase yield of these reactions, as well as to 
generalize the method for other amplicons, several optimization trials 
were undertaken in order to determine optimal PCR parameters. The 
products of these reactions were later purified using Ampure beads 
according to standard protocol, quantified with nanodrop UV 
spectroscopy, and checked for transcriptional fidelity via gel 
electrophoresis and Sanger sequencing. 
Several alternate polymerases, thermal recipes, and reaction 
buffers were tested several in order to find the optimal mixture for 
amplifying sequences less than 6 kb (kilobases) in length, and possessing 




utilizing human male DNA, unmethylated dNTP’s, and OneTaq 
polymerase as seen in the material and thermal recipes below: 
Table 1: Recipe for PCR Experiments.  
Reagents Volume Final Concentration 
GC Enhanced Buffer 10 μl 1X 
10 mM dNTPs 1 μl 200 µM 
10 mM Forward Primer 1 μl 0.2 µM 
10 μM Reverse Primer 1 μl 0.2 µM 
OneTAQ DNA Polymerase 0.25 μl 1.25 units/ 50 µl PCR 
Template DNA 1 μl < 1 µg / 50 µl PCR 
Nuclease-free H2O To 50 μl N/A 
 
Table 2: Thermal Recipe for PCR Experiments 











60 Seconds per kb 
Final Extension 68 °C 300 Seconds 





The amplicons generated were purified using AMPure beads95. This 
was accomplished by adding  paramagnetic beads, suspended in an 
optimized buffer, to the DNA samples at a ratio of 9:5. The buffer 
solution selectively binds larger pieces of DNA (greater than 100bp in 
length), to the suspended beads, while leaving the remaining salts and 
excess nucleotides in solution.  
The mixed samples are then kept on a magnetic rack for several 
minutes, separating the beads from solution. The beads are then washed 
twice in 70% ethanol, removing any contaminants that might still 
remain, and left to air dry for 15 minutes. Lastly, the dry beads are 
washed in TE elution buffer, separating the PCR product from the 
AMPure beads, and permitting extraction. 
3.2 – Gel Electrophoresis 
       To establish that PCR produced amplicons of an appropriate size, 
the purified products were then run through a process known as gel 
electrophoresis. Gel electrophoresis is one of the simpler methods for 
separating an analyzing fragments genetic material, based on their 
charge, and relative size. The process leverages several qualities of 
nucleic acid molecules in order to achieve this separation. DNA and RNA 
molecules both contain negatively charged phosphate backbones, giving 
them an overall negative electrical charge. When these molecules are 
subjected to an electric field, they are induced to move away from the 




This quality on its own however, is not enough to effectively 
separate or analyze nucleic acids. Both DNA and RNA are polymers, 
consisting of nucleotides that are held together by connecting sugar 
phosphate backbone. As a result, the overall charge density of such 
molecules remains constant, as the ratio of phosphates to nucleotides is 
1:1. To separate genetic fragments on the basis of size, another of their 
physical qualities will have to be exploited. Placing the material into a 
porous polymetric support such as an agarose gel, can cause longer 
strings of DNA to migrate at an appreciably slower rate despite being 
subjected to the same electrical field. What’s more, the specific 
relationship between distance traveled, and molecular weight of DNA, 
can be modeled with great accuracy. 
In these experiments, purified DNA and NEB 100bp ladder was 
combined with NEB gel loading dye. 2% 7x10 cm agarose gels containing 
LifeTech SYBR Safe DNA gel stain, were made in lab, and then and 
submerged in 0.1X TAE buffer in a Bio-Rad electrophoretic device. The 
mixed samples were loaded into the submerged gel, and run at 100 volts 
over the course of an hour. The gel was then taken out of solution, and 
imaged under ultra violet light, as seen in the figures below.  
 H/M_1 and B_1 amplicons generated from human male DNA with 
using this protocol presented bands corresponding to their molecular 
weight as compared with the NEB 100bp ladder (see figure below). This 




present 12 distinct bands on an electrophoretic gel. The fragments 
themselves are of known weight and concentration, providing a reference 
for the estimation of a given DNA products molecular weight.  
 
Figure 11: Gel Image of nested DNA samples H/M_1 and B_1. 
The size of each sample can be verified by comparing the propagation distance with the DNA ladder 
in lane 1. The relative weight of each band can be seen to the left of the gel. 
3.3 – Sanger sequencing 
       Sanger sequencing is one of several methods employed by 
molecular biologists to determine the genetic sequence of DNA samples in 
vitro. Originally developed by Fredrick Sanger in 197796, it was one of the 
most effective and popular methods of DNA sequencing for the remainder 




sequencing techniques. Though Next-Gen sequencing has become the 
standard method for dealing with genome sequencing, transcriptome 
profiling (RNA-Seq), DNA-Protein interaction (ChIP-Seq), as well as for the 
generation of epigenomic data97, Sanger sequencing is still widely used in 
laboratories to validate generated data. 
       Sanger sequencing works on principles very similar to traditional 
PCR. Both require DNA template which is denatured into single strand 
DNA, appropriately designed primers, a suitable polymerase enzyme, and 
deoxynucleotidetriphosphates (dNTP’s). Where Sanger sequencing differs 
however, is in the inclusion of chemically modified dNTPs called di-
deoxynucleotidetriphosphates, or didNTPs. Like dNTP’s they are capable 
of linking with other dNTP’s by forming an ester linkage at their 5’ 
carbon, thus becoming integrated in the new DNA strand. However, they 
lack a hydroxyl group at their 3’ carbon position, preventing other 
nucleotides from forming a similar bond, thus halting DNA elongation, 
and terminating the sequence. 
Sanger sequencing utilizes this property of didNTPs in the following 
fashion. The DNA sample to be sequenced is separated into four separate 
reactions, each one containing all four standard dNTP’s, polymerase, 
primers, as well as one of the four didNTPs, each reaction having a 
separate didNTP. Crucially, the didNTP is added in roughly 100-fold 
excess to its nucleotidic counterpart, meaning a concentration of 0.1mM 





Figure 12: Elongation of DNA Strand Using didNTPs 
Nucleotide elongation. Digital image. Early DNA Sequencing. Cold Spring Harbor Laboratory, n.d. 
Web. 4 Apr. 2015. 
 
Figure 13: Integration of didNTPs Halts Further Elongation. 
Nucleotide elongation. Digital image. Early DNA Sequencing. Cold Spring Harbor Laboratory, n.d. 




       Each of the four samples then undergoes PCR, which with the 
addition of didNTPs, results in fragments of transcribed DNA of varying 
levels of completeness, each terminating at a point along the genetic 
sequence corresponding to that reaction’s didNTP. The fragments from 
each reaction can then be loaded into separate lanes of a denaturing 
polyacrylamide-urea gel, and subjected to electrophoresis. This results in 
a series of bands propagating down the gel, each of which corresponds to 
a fragment of DNA which terminated at a particular point along the 
sequence. By cross referencing the distance each band has propagated to 
a molecular weight ladder, the specific didNTP inserted at a specific point 
along the sequence can be established, and by extension, the entire 
sequence can be determined. 
Since its initial development several technical variations have been 
employed to increase the experiments efficiency, and to increase 
automation. Tagging dNTP’s using flurophores99, or radioactive 
phosphorous, enables far greater throughput for this method. Labeling 
the chain terminating didNTPs, rather than dNTP’s is also a viable 
option, and permits Sanger sequencing to be conducted in a single 
reaction, rather than 4 separate ones. This technique, known as dye-
terminator sequencing, utilizes 4 separate fluorescent dyes 
corresponding to each of the four didNTPs. Following PCR, the fragments 
are then run through capillary electrophoresis, and stimulated with a 




This fluorescence is captured by a fluorescence detector, and can 
then be translated into sequence data. Numerous high-throughput DNA 
sequence analyzers have been designed to interpret such fluorescent 
data, making this method one of the more popular variants of Sanger 
sequencing. The GSTP1 amplicons produced via PCR, and validated via 
gel electrophoresis were sent to Genewiz for Sanger sequencing analysis. 




Figure 14: Consensus Identity for H/M_1 Amplicon vs. Genomic Target. 
The figure juxtaposes the generated Sanger sequence data with that of the target in the human 
genome, shown as lines one and two respectively. The green line above the sequences represents 
their overall agreement, indicating that the amplicon was reproduced successfully. The two green 




Figure 15: Consensus Identity for H/M_1 Amplicon vs. Genomic Target; HpaII/MspI Primers. 
This figure represents the same consensus identity, highlighting the target H/M_1 primers. The 
result indicates that the generated material is safe to use in later experiments, as this H/M_1 









Figure 16: Consensus Identity for B_1 Amplicon vs. Genomic Target. 
The figure once again juxtaposes the generated Sanger sequence data with that of the target in the 
human genome. Compared with the H/M_1 amplicon, there appears to be far less consensus 
between the B_1 Sanger sequence material, and the target region of the genome. However, the 
region between the two B_1 primers (shown as two green arrows) exhibits perfect consensus, 




Figure 17: Consensus Identity B_1 Amplicon vs. Genomic Target; BamHI Primers. 
This figure represents the same consensus identity, highlighting the target B_1 primers. The result 
indicates that the generated material is once again safe to use in later experiments, as this B_1 
amplicon was reproduced correctly. 
 
Results indicated that all amplicons had been transcribed 
completely and accurately, an important control before inserting the 
genetic material into bacterial plasmids, and repeating the process. 
3.4 – Molecular Cloning 
Molecular cloning is a process used by biologists for over forty 
years,100 which isolates specific fragments of DNA, and links them 
through traditional 3′ → 5′ phosphodiester bonds to a special DNA 
molecule known as a vector. The significance of such vectors, is that they 
can be inserted into separate host cells in vivo, where they, along with 
any bound genetic material, can be expressed directly, or replicated 




cloning, or expression vectors, these pieces of recombinant DNA can be 
easily amplified, sequenced, safely stored for long periods of time, and 
used for genetic functional studies such as this one. 
 Two types of vectors are most commonly used for molecular 
cloning:  bacteriophage λ vectors101, and E. coli plasmid vectors, which 
are ring-shaped extrachromosomal DNA fragments that replicate within a 
cell. Plasmids are naturally occurring circular dsDNA molecules that are 
retained separately from a cell’s chromosome. This exochromasomal DNA 
can be thought of as almost parasitic in nature, utilizing cellular 
machinery to duplicate itself every time the host cell divides. However, 
many naturally occurring plasmids contain genes which benefit the cell 
in some way, making this relationship more symbiotic than it would 
initially seem.101  
For example, many plasmids encode for the production of enzymes 
which protect against antibiotics, presenting a major problem for treating 
bacterial pathogens over time. Additionally, certain plasmids contain so 
called “transfer genes”, which generate proteins which can form into 
tubes known as “pili”, allowing for the transmission of plasmids to other 
host cells of similar species.102 This enables drug resistant plasmids to 
spread even faster, compounding the difficulty faced by modern medicine 
in preserving the usefulness of antibiotics. 
Though these qualities cause difficulties in modern medicine, 




contrast to the naturally occurring plasmids found in E. coli, cloning 
plasmids tend to be roughly 3kb in length, cut down to contain only the 
genetic material necessary for replication, and an insertion region for 
the ligation of the DNA of interest, making it far easier to work with. 
Additionally, the inclusion of various design elements, such as plasmid 
regions that code for resistance to antibiotics, or toxic minigenes which 
are disabled through the ligation of new genetic material, are often 
utilized.To ensure long term transcriptional fidelity of the target 
amplicons, purified samples were inserted into competent E. coli, using 
pMiniT from NEB as a cloning vector, using the following ratios 
 
Figure 18: Recipe for Vector Insertion Protocol 
NEB® PCR Cloning Kit Instruction Manual. Ipswich, MA: New England Biolabs, 2012. Web. Apr. 
2014. 
Reagents were mixed with an appropriate amount of each insert, 
determined through the following calculation: (3) (25 ng vector) (bp of 
insert / 2525 bp of vector). Each reaction was incubated at room 
temperature for 15 minutes, then quickly submerged in ice for another 2 




coli was removed from storage and allowed to thaw in ice for 10 minutes. 
Following the completion of both steps, timed to coincide, 2 μl of ligated 
insert was added to the competent cells, and gently mixed by flicking the 
tube several times. This combined reaction was then incubated on ice 
for another 30 minutes, followed by a heat shock of the sample at 42 °C 
for 30 seconds.  
The purpose of this incubation is to allow the bacterial membrane 
of the competent cells to stabilize, and then become coated with cations 
released by the ligation enhancers (primarily calcium cations provided 
from CaCl). This is believed to encourage negatively charged DNA to 
bind to the phospholipid membrane, though the mechanism is not fully 
understood. 103 Once bound, the heat shock temporarily alters the 
fluidity of the membrane of the competent cells, allowing the 
recombinant DNA to enter at a far more efficient rate. Following heat 
shock, the mixture is then incubated on ice for another five minutes, to 
reduce the thermal motion of DNA, ending the transformation step. 
 950 μl of Super Optimal Broth with Catabolite repression (SOC)104 
outgrowth medium is then added to the mixture, and it is left in a 
rotating incubator set at 250 rpm, and 37 °C, for one hour. Once 
completed, the mixture is gently mixed by flicking the side of the tube, 
and 50 μl of the outgrowth is then spread onto pre-warmed agar plates 
containing 100 μg/ml ampicillin. The plates are then left to incubate 




visible to the naked eye, individual colonies can then be carefully 
harvested using a spatula, and immersed in 5 μl of Lysogeny Broth (LB), 
also containing 100 μg/ml ampicillin, and left to grow for another 16-18 
hours rotating at 250 rpm in a 37 °C incubator. 50 μl of the outgrowth 
solution is once again spread onto a second set of pre-warmed 
ampicillin plates, left to grow overnight, producing clonal colonies.  
By design, the pMiniT vector contains two key mini-genes, the 
first being an ampicillin resistance gene, and the second being a toxic 
gene which inhibits protein synthesis. When genetic material is ligated 
to this vector, it is inserted directly at the site of the toxic mini-gene, 
thus nullifying its effect on transformed cells, while preserving 
ampicillin immunity. Any cells that absorb unmodified pMiniT during 
transformation will die as a result of the active toxic mini-gene, while 
cells that had not integrated any vector at all would die when grown out 







Figure 19 pMiniT Insert 
NEB® PCR Cloning Kit Instruction Manual.  
Ipswich, MA: New England Biolabs, 2012. Web. Apr. 2014. 
 
The only cells 
remaining would be 
that population that 
had integrated the 
pMiniT vector 
(containing purified 
DNA amplicon) into its 
plasmid DNA. This 
population would then 
replicate this inserted 
recombinant DNA 
along with its original 
host genetic material, 
generating a limitless 
supply of accurately transcribed target amplicons contained within the 
plasmid DNA of decedent bacterial clones. A colony of these affected 
clones can then be stored long-term as a bacterial glycerol stock, which 
can be used to generate more plasmid DNA without retransforming 





When desired, the DNA of spliced E. coli could be harvested by 
growing out a colony in lysogeny broth, pelleting the growth in a high 
speed centrifuge, and then lysing the cells. The plasmid DNA can then be 
purified out from the mixture of cellular debris, and if desired, and 
checked again for transcriptional fidelity using the same methods 
outlined above.  
3.5 – Endonucleic Binding 
 As a preliminary to EMSA, and other examination of protein-DNA 
binding dynamics, several experiments were run examining buffers that 
might prevent enzymic cleavage of unmethylated DNA. As mentioned 
previously, type II restriction endonucleases are only capable of cleaving 
at their target sites if there are magnesium ions present, which provide 
hydrogen bonds essential for adopting cleavage conformation. By using 
an Mg2+ free buffer, such as 10mM Tris-HCl 50mM KCl buffer, it was 
hoped that such activity could be halted, permitting examination of their 
binding behavior without destroying the target amplicons. 
This buffer combination worked exceedingly well, protecting the 
effected DNA in all experiments as long as a complete absence of Mg2+ 
was maintained. It is worth pointing out here that the presence of 
methylation can be confirmed visually by once again examining an 





Figure 20: Endonuclease Digestion Gel 
Each lane contained DNA sample incubated with an endonuclease, or water as a control. Note that 
the methylated samples are slightly heavier, and are resistant to cleavage (see lanes 3 and 6). 
Cloned plasmid matieral was also tested, and was cleaved at the 6 HpaII/MspI target sites, 
resulting in several smaller segments seen in lanes 11 and 12. 
 
 Having confirmed that the amplicons would be protected from 
cleavage, further data concerning their attractiveness to these 
endonucleases could be undertaken through EMSA.  
3.6 – EMSA 
As mentioned in previous sections, EMSA has been used in 
characterizing DNA binding proteins of all kinds, and has been of key 
importance in the identification and verification of MBPs. While not 
designed for high throughput, it is a robust and highly malleable method 
that can be adapted to accommodate numerous alternate experimental 
parameters. The amplicons procured in previous steps were designed to 
contain several target sites for HpaII/MspI, and BamHI activity. By 
incubating these enzymes with DNA in an Mg2+ free buffer solution at a 




their target strands. Under normal circumstances, the endonucleases 
would scan DNA strands until finding such a site, then change their 
binding conformation in order to cleave the strand in two, allowing it to 
disengage and search for more unmethylated genetic material.  
Without the magnesium, these enzymes should remain stuck to 
DNA, and remain in a protein-DNA complex sufficiently long for 
examination.Due to the high sensitivity of the assay, only 20 fmoles of 
each amplicon would be required for each reaction. These were combined 
with Tris-HCl KCl buffer, along with varying amounts of enzyme and TE 
buffer on ice, and then incubated at 37 °C for an hour to form protein-
DNA complexes, according to the table below.  
Table 3: Recipe for Equilibriation Reaction.   
Component Volume Final Concentration 
Tris-HCl KCl 25 μl 10mM Tris-HCl .5M KCl 
DNA 10 μl 20 fmoles 
Endonuclease 10 μl Varied 
Tris-EDTA 5 μl 1X 
Final 50 μl N/A 
Various neutral osmolytes, such as trimethylglycine were added to 
these equilibrated samples, as previous studies had shown that their 
addition had decreased the dissociation rate by a factor of ~75105,106. 
Similar findings had been made concerning the addition of CaCl2, 
purportedly increasing the half-life of BamHI specific complexes by 




electrodes in the Lifetech mini-gel tank, this was not attempted. 30 μl of 
the osmolyte mixture was added in order to “freeze” the reaction state, 
and prolong endonucleic binding. The concentration of this mixture 
varied, but proved effective so long as it was at least 200x the molar 
concentration of the bound DNA. 
While this endonucleation step was underway, a 5% 8 x 8 cm 
polyacrylamide gel was loaded into the tank, submerged in sufficient TBE 
buffer, and run at 100 V for several minutes in order to draw out any 
contaminants that might reside in the wells of the gel. Ideally the entire 
procedure would also take place in a cold room at around 4 °C.  
After both steps had been completed, the solutions were then 
mixed with an appropriate loading dye, and 15 μl of each sample 
carefully pipetted into the gel. To minimize “dead time”, during which the 
complexes have yet to enter the gel, electrophoresis was initially 
conducted at a high voltage (~400 V, or 50 V/cm) for 30 seconds.  
Once inside of the gel, as signaled by the loading dye, the voltage is 
lowered to 80 V, and run for another 45 minutes (10 V/cm). Due to the 
short half-life of the HpaII and MspI complexes, it was difficult to exceed 
this time limit without dissociation. Fortunately, 45 minutes was 
sufficient time for weight-shifted bands to emerge. The gel cassette was 
then removed from the electrophoretic apparatus, and laid well side up to 
dry. Using a gel knife, the cassette was carefully cracked open, allowing 




3.7 – Semi-Dry Electroblotting 
 The protein-DNA complexes that propagated down the gel need to 
be transferred to an appropriate membrane for downstream processing. 
Once accomplished, the bound material can be further analyzed in a 
variety of different ways, such as using specific antibodies, DNA stains, 
or ligands. For this method, Zeta-Probe membranes from Bio-Rad were 
used, though theoretically any appropriate nylon membrane would do. 
These membranes possess high density positive charge, which strongly 
attracts negatively charged DNA and protein-DNA complexes. When the 
gel, the membrane, and several sheets of buffer soaked filter paper are 
layered in a stack (see below), and are subjected to a strong positive 
voltage. Given enough time, the genetic material will transfer from the gel 
to the membrane, and 
be ready for further 
processing.  
 
Figure 21: Diagram of 
Transfer Stack  
(public domain image) 
Two sheets of 2.5 mm blotting paper soaked in TBE were first 
loaded onto the anode of the apparatus (no sponge is required in semi-
dry transfer), followed by the pre-soaked nylon membrane. A roller was 
used to ensure the membrane remained flush against the filter paper, 




membrane, flattened again with the roller, and then covered up with a 
final two sheets of blotting paper. The cathode lid of the blotter was then 
placed on top of the stack, completing the circuit and compressing the 
components together. The protein-DNA complexes were then transferred 
at 20 V for 60 minutes at room temperature.  
The stack was then disassembled, and the membrane was allowed 
to dry briefly on some kimwipes, before being transfered to the UV 
crosslinker. Crosslinking is required to ensure the genetic material 
remains bound to the membrane as it undergoes further processing. By 
subjecting the membrane to shortwave (254 nm) UV radiation, the 
nitrogenous bases of DNA become excited to such a state that they form 
covalent links with the embedded amine groups. This is easily achieved 
by subjecting the membrane to a short exposure of UV light, transferring 
roughly 120 mJ/cm2.  
 As mentioned previously, the amplicons designed for this study 
were produced from biotinylated primers, meaning the forward primer 
oligos had a biotin modification attached to their 5’ end, along with a six 
carbon length spacer to cut down on steric hindrance. 
 
Figure 22: Biotin with Spacer. Digital image.  









 Biotin is a very useful molecule for a number of molecular 
biological procedures due to its high affinity for the proteins avidin and 
streptavidin. By using biotinylated primers to generate amplicons, 
streptavidin-horseradish peroxidase (HRP) conjugate can bind itself to 
the resultant DNA. The HRP in turn efficiently catalyzes luminol 
oxidation, which when combined with certain chemicals, releases high 
intensity light in a process known as enhanced chemiluminescence 
(ECL). By immersing the membrane and crosslinked DNA in luminol 
working solution, the DNA, and protein-DNA complexes can then be 
imaged and subjected to further analysis. 
 To bring this about, the membrane was first immersed in 20 mL of 
blocking buffer for 15 minutes in a shaking container, to prevent non-
specific binding downstream. The buffer was then decanted, and then 
succeeded by 20 mL of another conjugate blocking solution, and once 
again shaken for 15 minutes. The membrane was then transferred to a 
new container, and washed in 20 mL of wash buffer for 5 minutes. This 
step was repeated a total of five times (the buffer being decanted each 
time), after which the membrane was transferred to yet another new 
container containing 30 mL of substrate equilibration buffer.  
 This was left to shake for another five minutes, while 
simultaneously a working solution was produced by combining 5 mL of 
Luminol/Enhancer solution and 5 mL of Stable Peroxide solution, 




round of buffer, blotted on a kimwipe to remove excess liquid, then 
placed on a clean sheet of plastic wrap, DNA side down. The working 
luminol peroxide solution was then poured onto the membrane, and left 
alone for another five minutes. 
 Once completed, the membrane was briefly blotted on another 
kimwipe, then wrapped entirely in plastic wrap, avoiding bubbles and 
folded edges where possible. The treated membrane could finally be 
imaged for chemiluminescence, allowing for examination of the results of 
the EMSA experiment. 
3.8 – qPCR 
A real-time, or quantitative polymerase chain reaction (qPCR) is a 
technique based off of traditional PCR, discussed above. As in PCR, it 
uses polymerase and other genetic material to amplify specific target 
DNA to detectable levels. The process of detection is a separate step in 
classical PCR, where the amplification product would be run through gel 
electrophoresis for characterization. In qPCR, this step is avoided 
entirely, seeing as it utilizes fluorescence detection methods to observe 
the creation of DNA products in real time as they are produced, and 
generating quantitative and / or qualitative data. This strategy not only 
saves time, but has numerous other beneficial aspects, as it removes 
much contamination risk associated with post-PCR manipulation.109 
DNA does not fluoresce on its own of course, so certain additional 




is the inclusion of non-specific fluorescent dye, such as SYBR Green I or 
EVAGreen, which emit light at 10,000x greater intensity once they are 
intercalated with double stranded DNA. During PCR, polymerase actively 
creates more and more double stranded amplicons of the target DNA. As 
this occurs, the dye binds with these new amplicons, and fluoresces in 
proportion to the amount of DNA produced in each cycle, and quantifying 
it in real time.  
 
Figure 23: SYBR Green. Digital image.  
Genomics & Proteonomics Core Facility. German Cancer Research Center, n.d. Web. 
<http://www.dkfz.de/gpcf/lightcycler480.html>. 
This particular assay is cheap, and much easier to set up than 
alternative methods, but it suffers from a number of drawbacks. For one, 
because of its non-specificity, the dye will bind to any available double-
stranded DNA, including unspecific products, primer dimers (forward 
and reverse primers binding to themselves), and the initial sample DNA, 
thus introducing bias into the quantification. This can be countered 
somewhat by running a melting curve after completion of PCR, which 
can theoretically identify the number different produced DNA amplicons, 
as well as their relative quantity. Melt curves are not perfect however, so 





qPCR is also capable of conducting qualitative analysis, detecting 
the presence or absence of a particular DNA sequence for example. In 
order to accomplish this, specific detection methods like double-dye 
probe systems, are required. Originally developed from a similar assay 
using radio-labeled probes110, double-dye probes are single stranded 
DNA molecules with fluorophores attached to their 5’ end, and a 
corresponding quencher attached to their 3’ end. The fluorophores emit 
light as it is excited by the energy of the thermocycler, but has its energy 
absorbed by the corresponding quencher via fluorescence resonance 
energy transfer (FRET), so it cannot fluoresce. As these probes are 
integrated into DNA, polymerase enzymes cut off the 5’ end of the probe, 
releasing the fluorophore into solution, and allowing it to fluoresce freely.  
By using several fluorophores, attached to separate sequence-
specific double-dye probes, researchers can track the production of 
several products being created simultaneously, with high accuracy. The 
method is also highly modular, and can be multiplexed with some 
forethought. On the other hand, using double-dyes, along with other 
quantification methods, is more expensive than qualitative qPCR, and 
tends to be utilized in situations where it is necessary to establish the 
presence or absence of particular alleles relative to one another. 
Integrating qPCR into this method poses several significant 
advantages. As mentioned above, it can achieve a wide variety of 




to generate qualitative and quantitative data of interest. In addition , it is 
especially well suited to biophysical modeling, as the plot of fluorescence 
of a titration standard curve can be used to determine the efficiency of 
amplification. Such linear regression modeling is not without flaws 
however, as current methods are highly affected by signal noise, which 
can produce significant variance in the generated data111.  
For the purpose of validating this method, qPCR was used to probe 
the integration efficiency of methylated vs. unmethylated dNTPs. As 
mentioned previously, the generation of fully methylated DNA template 
had proved difficult to achieve in certain isolated cases, particularly 
those involving amplifying regions with a high GC percentage. Examining 
the working efficiency of polymerase working with methylated dNTPs 
would generate valuable kinematic data. By integrating such findings 
into currently existing polymerase models, the appropriate ratio of 
methylated vs unmethylated dNTPs to use in generating randomly 
methylated amplicons could be determined. 
Several preliminary qPCR experiments were run to determine the 
appropriate quantity of template DNA to use in future experiments, as 
well as the digestion efficiency of the various endonucleases. The setup of 
these initial qPCR runs was very similar to that of conventional PCR. 
DNA amplicons, generated in previous steps, were measured for overall 




portions of the sample were aliquotted out, and subsequently diluted by 
factors of 10.  
 An aliquot with measured concentration of 14.6 ng/μl was utilized 
for the first digestion experiment. Two separate reactions were generated 
containing 150 ng of DNA, one intended for digestion, and the other 
intended as a control, as seen in the following table. Each was produced 
on ice, and then incubated for 1 hour at 37 °C. 
Table 4: qPCR Digestion Recipe  
Material Digestion Control 
DNA 7.1 μl 7.1 μl 
Cutsmart Buffer 5 μl 5  μl 
BamHI 1 μl 1 μl 
H2O 36.9  μl 36.9 μl 
Total Volume 50 μl 50 μl 
 
 Following digestion, the samples were treated using previously 
described PCR cleanup methods, in order to curtail any further cleavage. 
The resulting cleaned product was then used as template for qPCR, 
mixed together with the appropriate forward and reverse primers, and 
qPCR KAPA SYBR Fast Master Mix (containing ROX as a secondary dye) 







Table 5: qPCR Master Mix Recipe 
Material Digestion Control NTC 
DNA 21.6 μl 21.6 μl 0 μl 
F-Primer 1.44 μl 1.44 μl 1.44 μl 
R-Primer 1.44 μl 1.44 μl 1.44 μl 
Master Mix 37.44 μl 37.44 μl 37.44 μl 
H2O 10.08 μl 10.08 μl 31.68 μl 
Total Volume 72 μl 72 μl 72 μl 
 
 Once completed, 20 μl of each mixture were pipetted into three 
separate wells, making a total of 9 separate reactions. Conducting each 
reaction in triplicate cuts down on the risk of environmental 
contamination, or mechanical error adversely affecting the experimental 
data. The loaded plates would then be inserted into the qPCR thermal 
cycler, and run according to the programmed thermal recipe. Results and 





Chapter 4 – Results: 
4.1 – Fully Methylated DNA Amplicons 
As mentioned previously, several PCR experiments were run 
utilizing human male DNA as template, the appropriate primer pairs, and 
methylated dNTPs. Tests were initially successful in creating a limited set 
of completely methylated amplicons, specifically those examining the 
region containing the BamHI cleavage site. However, the majority of 
regions containing HpaII/MspI targets could not be amplified in the 
manner previously outlined.  
 
Figure 24: H/M_1 Unmethylated and Methylated Sample, vs B_1 Unmethylated amd Methylated 
Sample. Note the complete lack of sample for the H/M_1 Methylated sample across all temperatures 
tested, indicating additional factors were hindering the production of methylated H/M_1. 
To resolve this issue, several experiments were run testing the 




and DNA templates. Use of a methylated DNA template, generated using 
CpG methyltransferase, was also considered, and met with some 
experimental success. However, the issue was eventually solved through 
the design of additional primers to be integrated into nested PCR.  
That said, further examination of alternate means of offsetting the 
difficulty of working with 5-methyl-dCTP would be a useful area of future 
examination, as little work at present has been done on the subject. 
Considering the relevance of this issue with ongoing characterization of 
the effects of DNA protein-binding dynamics, new insights into the 
thermodynamic and biophysical forces at play here would be of 
considerable interest. 
4.1.1 – CpG Methyltransferase 
One of the steps taken to ameliorate the issues of working with 
this difficult set of amplicons, was the usage of CpG methyltransferase 
(M.SssI). M.SssI is an enzyme capable of methylating cytosine 
nucleotides it encounters in a CpG doublet. By taking PCR product 
produced with unmethylated dNTPs, and incubating it with CpG 
methyltransferase for several hours, all cytosines found in such a CpG 
configuration will become methylated. As a result of this methylation, the 
sequence itself will also be unable to be cleaved by methylation-sensitive 





Figure 25: Sssi Treated H/M Sample Digestion Gel. 
Samples were treated with Sssi Methyltransferase for either 12 or 18 hours, and then incubated 
with an endonuclease, or water as a control. Those samples incubated with MspI appear to be 
completely digested in both groups, while those incubated with HpaII enzyme emerged unscathed. 
This indicates the product was successfully methylated in both cases. A a slightly fainter band in 
lane 1 compared with lane 4 indicated that longer Sssi treatment period yielded better results. 
 
 By incubating the products with HpaII, MspI, and H2O as a 
control, it becomes clear that methylated product has been produced. 
While MspI is still capable of cleaving the product, methylation sensitive 
HpaII enzyme is no longer able to attack DNA, and clear bands still 
emerge in the same position as the control samples incubated with 
water. Testing suggested that incubations as long as 18 total hours were 
necessary for complete methylation of all CpG regions of this size, as can 
be seen in the slightly weaker band for the 12 hour HpaII incubation. 
Some product was lost as a result of incomplete methylation. 
However, such modification methods would not be sufficient for 




cytosines in CpG doublets. In the sequence 5’ – CCGG - 3’ for example, 
only the second C would be altered by this treatment, leaving the 
external cytosine unchanged. This is sufficient for the purposes of 
protecting the sequence from endonucleic cleavage, hence its usefulness 
for E. coli, but not for a method generating entirely random methylation. 
It was initially hypothesized that the difficulty of generating 
completely methylated H/M_1 might be ameliorated by using an 
alternate DNA template, such as entirely methylated genomic DNA, or 
DNA partially methylated via CpG methyltransferase. However, as this 
added additional complication to the method, several additional primers 
were designed to generate larger amplicons that contained within them 
either the H/M_1 or B_1 regions of interest, for nested PCR.  
4.1.2 – Nested Polymerase Chain Reaction 
As its name implies, nested PCR utilizes two sets of primer pairs, 
where the first pair is used to generate product which will be used as 
DNA template for the 
second pair of primers 
(in a subsequent PCR 
run).  
Several of such pairs 
were designed to nest 
successful amplicons 





within larger regions of roughly 1000-2000 base pairs in length. 
However, the majority of those designed performed rather poorly, likely 
due to the high GC content of the region, despite several attempts to 
optimize thermal recipes for each product.   
Eventually, two appropriate pairs were identified that amplified 
sufficiently well to be used for nested PCR with H/M_1 and B_1, namely 
H/M_61C, and B_1.1K. These samples were generated in the same 
manner previously described, and can be seen below. H/M_61C was the 
strongest candidate by far with high yield and consistency, though only 
producing product when the annealing temperature of the thermal recipe 
was set above 63 ° C. All three tested extended amplicons for B_1 were 
successful, though 1.1K had the best overall performance and yield. 
 
Figure 27: Gel Electrophoresis of External Nested Amplicons. 
Lanes 4 through 7 contain sample of amplicons containing either H/M_1 or B_1 nested within them. 
Lanes 2 and 3 were a failed attempt to use an alternate polymerase (Q5), and show clear signs of 




  These amplicons were then purified, and used in successive 
rounds of PCR with the original primer sets, and methylated dNTPs. This 
at last produced the appropriate methylated products, as can be seen in 
the gels below.   
 
Figure 28: Methylated H/M_1 Generated from Nested Material.  
H/M_1 amplicon was generated via nested PCR reaction, using either H61C or H/M_1 amplicon as 
a DNA template for amplification. Lanes 2 through 5 used H61C and normal dNTP’s performed 
poorly, presenting with a large secondary band due to an overload of template DNA. 
Those using methylated dNTP’s used H/M_1 amplicon as template, and appeared to be generated 
successfully. Note the slight weight shift due to added molecular weight from methyl groups, 
indicating successful generation of methylated product. 
 
 
Figure 159: Verification of H/M_1 Product Methylation. 
Samples of methylated and unmethylated H/M_1 were generated, and then digested with one of 
three endonucleases. Unmethylated sample was digested in all three cases (even by BamHI, 
indicating star activity), while methylated H/M_1 was unscathed. A secondary control was run in 
lanes 10 through 12, generating H/M_1 amplicon, using H/M_1 as a template, with no polymerase.  
Bands present where expected, indicating that the central samples were completely methylated. 




Though subtle, it can be noted even in this image that the procedure has 
been a success. The slight upward shift of the methylated H/M_1 
amplicons seen on the right can be attributed to the additional methyl 
groups found on each cytosine. Methylation status was further verified 
by digesting the material using HpaII, MspI, and BamHI as a control. 
With this completed, probing into protein DNA interactions could begin. 
4.2 – EMSA Experiments 
 Numerous EMSA experiments were conducted in order to optimize 
protein-DNA complex half-life, and transfer fidelity. One of the first of 
such experiments was conducted to determine the sensitivity of the 
assay itself with our imaging tools. Various 3-fold dilutions of B_1 control 
amplicon were incubated without endonuclease and run through the 
described EMSA protocol, producing the image seen below.  
 
Figure 30: Initial EMSA Experiment.  
Numerous extraneous bands indicate insufficiently clean product. The expected band is indicated 
by the red arrow to the left. As the samples become more dilute, the extraneous bands fade away 





Table 6: Amount of DNA Used in Initial EMSA Experiment  
Lane No. 1 2 3 4 5 6 7 8 9 10 
fMoles B_1 2,974 991 330 110 37 12 4 1.4 0.5 0.2 
The assay itself was more sensitive than initially expected, and revealed 
the considerable impurity of the sample utilized. The lowest band was 
the anticipated B_1 amplicon, but the majority of wells presented with 
additional bands above this point at lower intensity, indicating 
contamination of the product. Later examination of the sample traced 
this back to non-specific priming in PCR, which was resolved by 
increasing the annealing time and temperature. The results of the 
modified procedure can be seen below. 
 
Figure 31: Modified EMSA Experiment. Bands uniform and presented where expected in gel. 
Old sample shown in row 9 for comparison. Two of the new samples tested, B1 and B5 still 




Using the appropriate amount of clean DNA results in clear bands 
presenting where expected on the gel. For comparison, the original 
sample used in the previous image can be seen in well 9. A DNA ladder 
was also utilized for this experiment, though it presented fainter bands 
than were hoped. Initial tests intended to preserve bound protein-DNA 
complexes were not very promising. No matter how much enzyme was 
used, or how rapidly EMSA could be completed, nearly all bound 
endonuclease appeared to separate from its target DNA by the time it 
had been transferred to the nylon membrane, resulting in uniform bands 
without weight shift, as seen in the image below. 
 
Figure 32: Negative EMSA Result 
While DNA samples were successfully protected from cleavage while incubated with various 
endonucleases, none of the lanes presented with a strong, discernable weight shift; indicating that 
any protein-DNA complexes had since dissociated. Only a small amount of DNA-protein complexes 
remained bound, as evinced by faint trailing bands. 
 The addition of neutral osmolytes as a means of extending complex 




results. B_1 amplicons were designed to have only one BamHI restriction 
site, meaning that if BamHI were to bind to its target site and remain as 
a stable complex, a distinct upward shift should be observed. While a 
shift was evident, indicating that some amount of endonuclease had 
bound to the available DNA, the bands presented were smeared, 
indicating that rapid association and dissociation of the complex was 
occurring. All else being equal, the more available enzyme in the local 
vicinity, the more likely a given restriction site is occupied at any given 
time. The greater the amount of restriction enzyme therefore, the greater 
the shift, until a point where there is sufficient enzyme to make all 
available DNA functionally permanently bound.  
 
Figure 33: Neutral Osmolyte Experiment.  
The lanes on the left were treated with neutral osmolytes, while those on the right were not. 
At lower concentrations of BamHI, there is little sign of weight shift in either set of samples. 
However as concentration increases, this shift becomes far more noticeable and uniform in the 
osmolyte treated samples, for example in lanes 7 and 8. An additional band seen in the osmolyte-
free samples can be seen, but was determined to be a result of sample contamination, and not of 





Figure 34: Additional EMSA Experiment with Osmolytes  
Repeat of previous test. Note again the signs of streaking seen in lanes 9 through 11.  
These indicate a complete saturation of all binding sites on the DNA sample, with a weight shift 
corresponding to the additional BamHI enzyme.  
 This last point can be illustrated quite well in the following image. 
Utilizing neutral osmolytes, as well as other optimization techniques, 
clear bands emerge when the molar concentration of BamHI exceeds that 
of the DNA strands by a factor of over 200.  
 
Figure 35: Effect of Osmolytes on B_1 Protein Complex Half-Life. 
This run used non-biotinylated ladder that presented visual bands, as opposed to fluorescent ones.  
The image is a composite of two separate imaging techniques, colorized for ease of visualization. 




Table 7: Amount of DNA and Protein Used in Osmolyte Experiment 
Lane No. fMoles BamHI fMoles B_1 Sample BamHI/B_1 Ratio 
1(Ladder) 0 0 N/A 
2 0 20 N/A 
3 6.67 20 0.33 : 1 
4 20 20 1:1 
5 60 20 3:1 
6 180 20 9:1 
7 540 20 27:1 
8 1,620 20 81:1 
9 4,860 20 243 : 1 
10 12,660 20 632 : 1 
 
 This indicates that the method is capable of generating stable 
protein-DNA complexes of a sort by brute force. The shift itself is far 
greater than expected, with the molecular weight of a BamHI dimer being 
roughly 75 kD (kilo Daltons), and the bands in wells 7 & 8 exceeding 250 
kD. This would imply that their stability is a result of both specific, and 
non-specific binding to the strand. Type II restriction endonucleases first 
bind non-specifically to DNA, then locate their target sites via linear 
diffusion.112 Several BamHI dimers therefore could exist on the strand 
simultaneously, stuck in a traffic jam of sorts, until they themselves 
dissociate.  
The desired shift can be observed in well 6, with an observable 




single bound BamHI dimer. This affirmative result however, is hardly 
ideal. The band is highly smeared, rather than a solid band, indicating 
that a sizable portion of the complexes had dissociated before the 
completion of EMSA. Numerous subsequent runs presented similar 
bands, which appear to be symptomatic of the short half-life of non-
cleaving endonucleic activity.  
Future experiments will explore potential ways to extend this time 
period, or to optimize the EMSA experimental protocol sufficiently to 
render it useful for even the most difficult of protein-DNA complexes. The 
utilization of formaldehyde crosslinking, to permanently bind 
endonucleases to DNA after equilibriation, might be a viable first step, 
though such measures would contaminate data concerning binding 
strength. Further attempts will undoubtedly shed light on these issues. 
4.3 – qPCR Analysis  
The results from the initial experiment outlined in the qPCR 




Plot of Initial 
qPCR 
Experiment.  







utilizing 150 ng 
of B_1 
amplicon as starting material, and either 0 or 1 μl of BamHI enzyme. The green line represents a 




In this and all subsiquent figures the y-axis corresponds to the 
level of fluorescence detected during amplification after a given number 
of cycles of amplification, seen on the x-axis. The lines themselves 
represent the average fluorescence data detected for the three triplicate 
wells for each reaction, as described above. As more and more 
amplification cycles takes place, the measured fluorescence of any well 
containing amplified genetic material will increase, until reaching a 
saturation point. 
The results of this particular experiment indicated that digestion 
efficiency of these restriction endonucleases had been overestimated 
somewhat, and that either too little enzyme had been used, or far too 
much DNA. Despite the fact that an hour of digestion had taken place, 
there was noticeable fluorescence observed from the digested wells 
starting at cycle 0 (initial conditions). This is to be expected of course, as 
the digestion of DNA results in the creation of smaller fragments of that 
same DNA, rather than its complete destruction. However, this 
fluorescence was not expected to increase, as the primers and 
polymerase should be unable to amplify such cut up material.  
It seemed very unlikely that contamination of some sort had taken 
place, as the no template control had become amplified after over 30 
cycles of PCR. This, along with the very quick amplification of the 
undigested material, indicated that far less DNA template would be 




titration run was conducted, examining the PCR amplification curves of 
various dilutions of the same genetic material. The results of this run can 
be seen below.  
 
Figure 37:  Amplification Plot of B_1 qPCR Titraion 
Samples were created via serial dilutions by a factor of 10, and through a standard qPCR reaction. 
All else being equal, the relative speed at which a given sample reaches fluorescence saturation is 
dependent entirely on the amount of starting material in each sample reaction. The effect of different 
quantities of DNA template can be clearly seen in the uniform spacing of each amplification curve. 
The results were precisely as expected, with the curves evenly 
spaced relative to their starting concentrations. Similar curve spread was 
observed in subsequent tests involving alternate amplicons, as can be 
seen below.  
 
Figure 38: Amplification Plot of H/M_1 qPCR Titration 
This run was the result of a similar series of serial dilutions, using H/M_1 samples instead of B_1. 
These performed as expected, with uniform spacing. Samples 7 through 11 were additional H/M_1 




 Given the exponential growth of product during PCR, and the 
linear relationship between the amount of this product and measured 
fluorescence, the starting amount of product is the prime deciding factor 
determining the number of cycles required to achieve fluorescence 
saturation. With this in mind, a far smaller quantity of starting product 
was utilized in future trials, hovering around the 1 pg range so as to 
center the control curve at twenty PCR cycles.  
In order to test the rate of integration of varying levels of 
methylated dNTPs via qPCR, new reaction mixtures would need to be 
produced containing these altered nucleotides. Proprietary information 
regarding the KAPA qPCR master mix utilized in previous experiments is 
not available information, but the key ingredients were known to be 
SYBR Green, OneTaq polymerase, and 2.5 mM MgCl2113.  
Initial experiments were run utilizing NEB OneTaq, and EvaGreen 
dye, which has been shown to outperform SYBR Green in terms of the 
robustness of its generated PCR signal, and its sharper and stronger melt 
peaks113. Using otherwise identical recipes as detailed in the PCR 
section, with either completely methylated or completely unmethylated 
dNTPs and 1X concentrated Evagreen dye, several qPCR tests were run 
to see their relative amplification performance. The amplification and 





Figure 39: Amplification Plot for Initial EvaGreen qPCR Experiment 
Each reaction was generated using the standard recipe, using NEB OneTaq and Evagreen dye. 
Despite using a relatively high amount of starting material, each reaction reached a saturation point 
after the expected amount of cycles, regardless of methylation status.  
 
Figure 40:  Melting Curve Plot for Initial EvaGreen qPCR Experiment 
Melting curves are generated by measuring total fluorescence of sample over a wide range of 
temperatures. As temperature increases, dsDNA begins to dissociate, freeing the fluorescent dye, 
and thus lowering fluorescence. Assuming the majority of dsDNA is represented by the target 
amplicon, the total amount of fluorescence will dip sharply when it’s specific melting point is 
reached. By taking the first derivative of this fluorescence data vs temperature, a peak should 
emerge indicating the presence of these DNA compounds, centered roughly at the same point. 
An example of these peaks can be seen here. Note the effect of methylation on peaks for both 
H/M_1 and B_1, shifting both up several degrees.  
Results were mixed, but still largely positive. While each reaction 
took several cycles longer to reach fluorescent saturation than those 




still outperformed the NTC. Additionally, due to the lack of optimization 
with this novel reaction mixture, sluggish reactivity could be reasonably 
explained. Examination of the melt curves was far less encouraging 
however. While the B_1 samples presented with distinct peaks, with the 
methylated amplicon melting at a slightly higher temperature as 
expected, the H/M samples appear to have melted with two separate 
peaks, indicating non-specific, or inaccurate PCR amplification. These 
findings were cross referenced using programs like UMelt from the 
Wittwer Lab at the University of Utah. Using various peer-reviewed 
algorithms, it can produce highly accurate predictions of DNA melting 
curves and denaturation profiles114. The predicted melting curves for 
H/M_1 and B_1 are shown below. 
          
Figure 41:  uMelt Prediction for Initial H/M_1 Sample; Compared with Experimental Result.  
Both images show the derivative of fluorescence over temperature, and the Y axis of the uMelt 
image is shown in terms of the derivative value. The Y axis of the experimental image is in terms of 
raw fluorescence, but represents the same curve none the less. 
While the experimental curve presents with two peaks corresponding roughly to those predicted by 
uMelt, the low fluorescence of the secondary peak indicates very poor yield. Further optimization of 




          
Figure 42: uMelt Prediction for B_1 Sample; Compared with Experimental Result. 
Both images show the derivative of fluorescence over temperature, and the Y axis of the uMelt 
image is shown in terms of the derivative value. The predicted and experimental results for B_1 
appear to be slightly more accurate, with the fluorescent peak appearing at 87°C. 
 Even allowing for the slightly more rounded curve, a result of the 
exceedingly high GC % of H/M_1, the melting profiles of both the 
methylated and unmethylated samples bore little resemblance to this 
prediction. B_1 samples on the other hand, matched in both the location 
of their melting peaks, as well as the general shape of their dissociation 
curves. 
 Several attempts were made to optimize the H/M_1 qPCR reaction, 
with trials of various different polymerases, and alternate thermal 
profiles being considered. Ultimately, a high increase in Tm, while 
maintaining the usage of OneTaq polymerase, produced the most 






Figure 43: Melting Curve Plot for High Tm qPCR. 
Performance for H/M_1 product was improved substantially as compared with the previous graph. 
Note the uniform shape and high measured fluorescence for both methylated and unmethylated 
product. Again, the methylated sample melted at an inflated temperature. 
 
The peaks themselves were far more in line with those predicted by 
uMelt, and were observed in subsequent trials as well. The shift to the 
right of the graph observed for the methylated dNTP sample can once 
again be attributed to the presence of methylation, which has been 
reported to increase overall melting temperature in CpG methylated 
DNA115.  
The melting curve also appears to have substantially improved, 
eliminating additional peaks and exhibiting the expected shape and 





Figure 44:  uMelt Prediction for Alternate H/M_1 Sample; Compared with Experimental Result.  
Both images show the derivative of fluorescence over temperature, and the Y axis of the uMelt 
image is shown in terms of the derivative value. The Y axis of the experimental image is in terms of 
raw fluorescence, but represents the same curve, at a different relative scale. While the 
experimental curve appears to peak slightly higher than predicted, the overall shape of the curve is 
maintained. Note the smaller secondary peak at 80°C. 
However, these results are not proof positive of the presence of 
completely methylated product, as those peaks might result from non-
specific amplification. Further follow up experiments examining these 
results will be required moving forward. 
4.4 – Methylated Libraries 
 With these positive results, the final step required for evaluation of 
this method was the generation of methylated DNA libraries. Their 
creation involved several previously discussed steps, beginning with the 
amplification of template DNA utilizing varying levels of methylated 
dNTPs via PCR, followed by a process bisulfite conversion for 




These treated products were then prepped for library integration by 
ligating NEB Next adaptors to either end of the double stranded 
amplicons, which serve as platforms for the annealing of specific 
identifiable DNA barcodes, and new primers for next generation 
sequencing. Due to the specific design of the amplicons utilized, 
fragmentation and size selection steps are not required, decreasing the 
overall work load and ensuring greater downstream accuracy. 
 
Figure 45: EpiNext Barcode.  
Digital image. NEB Next Ultra DNA 








11 PCR reactions were 
incubated using the same components and thermal recipes previously 
described, with ratios of unmethylated to methylated dNTPs varying 
according to the following tables: 
Table 8: qPCR Sample Methylation Percentage with Corresponding dNTP Volume. 
% Methyl 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
dNTPs (μl) 20 18 16 14 12 10 8  6  4  2  0 μl 
5MdNTP(μl) 0  2 4 6 8 10 12 14 16 18 20 μl 
Master Mix 
(μl) 
30  30  30  30  30  30 30  30  30  30  30 μl 
Total Vol. 
(μl) 




Table 9: qPCR Master Mix, no dNTPs.  
Master Mix Components Volume 
GC Reaction Buffer 132 μl 
Forward Primer 13.2 μl 
Reverse Primer 13.2 μl 
Nested Template DNA 13.2 μl 
NEB OneTaq Polymerase 3.3 μl 
H2O 221.1 μl 
Total Volume 396 μl 
 The completed reactions were then cleaned up utilizing Ampure 
beads, and ethanol precipitation. The amplicons were then treated with 
Lightning Conversion Reagent from the EZ DNA Methylation-Lightning 
Kit from Zymo Research. This reagent sulphonates non-methylated 
cytosine nucleotides found in solution, which can then be converted to 









 Zymo Research Corp. 
(2013). EZ DNA 
Methylation-Lightning™ 
Kit. Irvine, CA: Zymo 
Research Corp. 
 
20 μl of each 
cleaned sample 
was mixed 
together with 130 
μl of the 
Lightning 
Conversion 
Reagent, centrifuged, and incubated at 98 °C for 8 minutes, then 54 °C 
for 60 minutes. The sulfonated products were then transferred to filtered 
spin columns, and treated with 600 μl of m-binding buffer and spun at 
10,000 g for 30 seconds. The resultant flowthrough was discarded, 
replaced by 100 μl of m-wash buffer before being spun again for another 
30 seconds.  
 200 μl of desulphonation buffer was then added to each column, 
which was left to sit for 20 minutes, permitting the reaction to run to 
completion. Once elapsed, the columns were centrifuged again for 30 




subsequent 30 second centrifugation. Finally, 10 μl of elution buffer was 
added to each column, which were centrifuged a final time for 30 
seconds, producing bisulfite treated DNA samples. 
 To anneal the adaptors for NEBNext, the ends of each amplicon 
would need to be “polished” so as to present with a 3’ adenine tail, and 
appropriate 5’ phosphorylation. This was accomplished by mixing each 
treated sample with NEBNext End Prep Enzyme Mix, and End Repair 
Reaction Buffer according to the following table. 
Table 10: NEBNext End Prep Recipe. 
Components Volume 
End Prep Enzyme Mix 3.0 μl 
End Repair Reaction Buffer 6.5 μl 
Treated DNA (>1 μg) 55.5 μl 
Total Volume 65 μl 
Each reaction was incubated for 30 minutes at 20 °C, then another 
30 minutes at 65 °C. The reactions were then permitted to cool to 4 °C 
before moving on to adaptor ligation. Ligation was accomplished by 
adding the following components directly to each reaction. 
Table 11: NEBNext Ligation Recipe 
Components Volume 
Blunt/TA Ligase Master Mix 15 μl 
NEBNext Adaptor for Illumina 2.5 μl 
Ligation Enhancer 1 μl 





 The reactions were mixed, and left to incubate at 20 °C for another 
15 minutes, after which 3 μl of USER Enzyme were added to each 
ligation reaction, in order to cleave the adaptor, leaving a pool of 
appropriately treated strands. Further treatment was not necessary, as 
the initial DNA products 
were all of appropriate 
length for usage in a DNA 
library.  
 
Figure 47: Adapter Ligation.  
Digital Image. NEB Next Ultra DNA 





  These titrated methylated library prepped samples could then be 
run through qPCR. The concentration of each DNA sample was 
established via uv-vis spectroscopy, and was added together with KAPA 
SYBR Fast qPCR Master Mix according to the following table. 
Table 12: KAPA SYBR Fast qPCR Master Mix Recipe 
Component Volume Final Concentration 
2X KAPA SYBR Fast qPCR 
Master Mix 
10 μl 1X 
10 mM Forward Primer 0.4 μl 0.2 mM 
10 mM Reverse Primer 0.4 μl 0.2 mM 
Template DNA Varied 20 ng / 20 μl  
H2O To 20 μl N/A 





These reactions, along with 6 standard reactions containing a fixed 
amount of DNA for comparison, were then loaded onto a 96 well plate in 
triplicate, inserted into a thermocycler, and run according to the 
following thermal recipe for qPCR. 
Table 13: Thermal Recipe for KAPA qPCR 
Step Temperature Duration Cycles 
Enzyme Activation 95 °C 300 seconds  1 X 
Denaturation 95 °C 30 seconds 
35 X Annealing / 
Extension 
60 °C 45 seconds 
Dissociation 
95 °C 60 seconds 
1 X 55 °C 30 seconds 
95 °C 30 seconds 
The resultant amplification data can be seen below. 
 
Figure 48:  qPCR Methylated Titration Amplification Plot  
With the exception of a few outliers at higher methylation percentages, the curvature of each group 
of samples appears highly uniform, and reaches fluorescent saturation after roughly 12 cycles. This 
uniformity is to be expected given the utilization of the same amount of starting material, amplifying 
the same product with varying degrees of methylation. 
As can be seen in the figure, the fluorescence curves are all 
surprisingly uniform, with the majority of samples achieving saturation 




reactions containing the greatest concentration of methylated material, 
80% 90% and 100% methylated template, all defy this trend, with the 
former two samples saturating at a slower rate, and the latter doing so 
much faster. The presence of these outliers can be explained by 
examining the standard samples. The amplification data for these 
samples can be seen below. 
 
Figure 49:  qPCR Methylated Titration Control Standard Amplification Plot. 
The standards were designed with specific quantities of known material which can be used to 
create a comparative standard curve. By comparing experimental samples to this curve, the total 











Table 14: qPCR Methylated Titration Standards, Quantity Derived from Fluorescence 
Replicate Well Name Well Type Quantity  
12 Std. 1 Standard 2.00e+001 
13 Std. 2 Standard 2.00e+000 
14 Std. 3 Standard 2.00e-001 
15 Std. 4 Standard 2.00e-002 
16 Std. 5 Standard 2.00e-003 
17 Std. 6 Standard 2.00e-004 
The standards correspond to standardized qPCR reactions with 
known concentrations and quantities of DNA. This information can be 
utilized to create a standard curve to help determine the initial quantity 
of product utilized in each sample. This curve can be seen below. 
 
Figure 50  Standard Curve Plot from qPCR Fluorescence Data. 
Control standards are shown as squares, and experimental standards are shown as triangles.  
Samples 9 through 11, with a methylation percentage ranging from 80% to 100%, are the outliers 




As can be seen in the figure, the majority of samples appear to 
present with between 2 and 3 initial copies, with two outliers below 1, 
and a final outlier beyond 10. These specific initial quantities can be seen 
in the table below. 
Table 15: Generated qPCR Methylated Titration Samples, Quantity Derived from Fluorescence 
Replicate Well Name Well Type Quantity 
(copies) 
1 0% Meth Unknown 2.58 
2 10% Meth Unknown 3.60 
3 20% Meth Unknown 2.23 
4 30% Meth Unknown 2.02 
5 40% Meth Unknown 2.32 
6 50% Meth Unknown 2.97 
7 60% Meth Unknown 2.00 
8 70% Meth Unknown 2.07 
9 80% Meth Unknown 0.739 
10 90% Meth Unknown 0.403 
11 100% Meth Unknown 16.87 
This indicates a small degree of experimental error in the 
measurement of the initial concentration of methylated product, and 
accounts for their deviation from the otherwise uniform threshold cycles. 
Accounting for this error, it appears that the generation of this library 
was largely successful. However further analysis of the resultant material 




4.5 – Conclusion 
While the method here described was successful in the generation 
of a library of randomly methylated material, there remains much work 
to be done in order for it to express its full potential. As documented 
previously, several amplicons containing a high GC percentage (~75%) 
were notoriously difficult to methylate consistently, and this issue 
resulted in several downstream experiments involving EMSA and qPCR to 
focus primarily on alternate control amplicons, in particular B_1.  
These difficulties were entirely unexpected, and the process of 
optimizing experimental procedure in order to overcome this hurdle was 
further hindered by lack of prior work examining the thermodynamics of 
integration of methylated dNTPs, and to a much lesser extent, GC rich 
PCR. Appropriate procedures for generating consistently methylated 
H/M_1 amplicons were eventually determined, but it is difficult to predict 
whether such methodology will be applicable to optimizing alternate 
difficult amplicons. Further work involving a range of epigenetically 
relevant promoter regions will be required in order to probe this issue, 
which should be done in tandem with thermodynamic characterization 
experiments in order to appropriately address this issue. Until this is 
accomplished, this method can only generate biased randomly 
methylated DNA libraries, as opposed to libraries containing unbiased, 




Additionally, much work will be required to establish the relevance 
and usefulness of this method in downstream analysis. Integrating this 
method with further forms of analysis, such as Bisulfite chromatin 
immunoprecipitation sequencing (BS-ChIP-seq), hydroxyl radical 
cleavage, and nanopore force spectroscopy, researchers will be able to 
generate a far more complete picture of any given protein-DNA 
interaction.  
BS-ChIP-seq can be utilized to determine the equilibrium state of 
protein binding to DNA at various epigenetic states. Hydroxy radical 
cleavage can reveal conformational structure of methylated DNA in vivo, 
as well as the precise location of protein binding via footprinting. Finally 
nanopore force spectroscopy enables high-throughput examination of 
protein-DNA binding strength as compared to a given binding threshold, 
or on a case-by-case basis via force modulation. 
In other words, much further work will be required before this 
method can be said to have achieved its initial aims. However, given the 
difficulty of determining the specific mechanisms behind the effects of 
DNA methylation on gene expression, it appears clear that further work 
towards reaching this potential is warranted. The rewards of a fully 
optimized method that can probe the mechanisms behind the impact of 
methylation on protein-DNA interactions are enormous, and more than 














HpaII/MspI_1_F 5’ – GGTCCTCTTCCTGCTGTCTG – 3’ 20 252 
HpaII/MspI_1_R 5’ – GCCTCCGAGCCTTATAAGGG – 3’ 20 252 
BamHI_1_F  5’ – CCCACTGGTTTGGAGTCTCC – 3’ 20 197 
BamHI_1_R 5’ – ATCCTGTCCACTTCAGCTGC – 3’ 20 197 
4K_Full_Forward 5’ – AACAAACCTGCACATCCTCT – 3’ 20 4011 
4K_Full_Reverse 5’ – CTCATTTCCCTCCATCCTGG – 3’ 20 4011 
2K_HpaII/MspI_R 5’ – TAACCTCAGTGGGTCTCAGT – 3’ 20 1929 
2K_BamHI_F 5’ – ACTGAGACCCACTGAGGTTA – 3’ 20 2102 
1.1K_HpaII/MspI_F 5’ – GCAGATCACCTAAGGTCAGG – 3’ 20 1111 
1.1K_HpaII/MspI_R 5’ – CAGACACATGCTCCTACCTC – 3’ 20 1111 
1.1K_BamH_F 5’ – ACTGAGACCCACTGAGGTTA – 3’ 20 1153 
1.1K_BamHI_R 5’ – GACACCAGAGTCCCAGATTC – 3’ 20 1153 
0.5K_HpaII/MspI_F 5’ – TTTCCTTTCCTCTAAGCGGC – 3’ 20 443 
0.5K_HpaII/MspI_R 5’ – GTACTCACTGGTGGCGAAG – 3’ 20 443 
0.5K_BamHI_F 5’ – AGCAACTGGTGGTTTCTGAT – 3’ 20 541 
0.5K_BamHI_R 5’ – GACACCAGAGTCCCAGATTC – 3’ 20 541 
H/M_60_F 5’ – AAACCATCATGGCGCACACACCT – 3’ 23 1181 
H/M_60_R 5’ – AGAAAAGTTTGCTGGAGCCCGGG –3’ 23 1181 
H/M_61_F 5’ – GGGATCGCAGCGGTCTTAGGGAA –3’ 23 827 
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